WO2021233314A1 - METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF - Google Patents

METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF Download PDF

Info

Publication number
WO2021233314A1
WO2021233314A1 PCT/CN2021/094459 CN2021094459W WO2021233314A1 WO 2021233314 A1 WO2021233314 A1 WO 2021233314A1 CN 2021094459 W CN2021094459 W CN 2021094459W WO 2021233314 A1 WO2021233314 A1 WO 2021233314A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
group
alkyl
hydroxyl
formula
Prior art date
Application number
PCT/CN2021/094459
Other languages
French (fr)
Chinese (zh)
Inventor
傅东林
王世胜
张亚珍
肖中平
张真庆
Original Assignee
绿谷(上海)医药科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 绿谷(上海)医药科技有限公司 filed Critical 绿谷(上海)医药科技有限公司
Publication of WO2021233314A1 publication Critical patent/WO2021233314A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/033Uronic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Provided is a method for economically and efficiently preparing β-D-(1,4)-mannuronate oligosaccharide as represented by formula (IX). Particularly, the method comprises: using economical and easily available 1,2,3,4,6-penta-O-acetyl-D-mannopyranose (formula X) as a raw material to prepare a key intermediate compound (I), compound (II), and compound (III); coupling the intermediate compounds (II) and (III) into an oligosaccharide receptor compound (V), and coupling the intermediate compounds (I) and (II) into an oligosaccharide donor compound (VII); and coupling the compound (V) and the compound (VII) into an oligosaccharide compound (VIII), and performing protecting group removal on the oligosaccharide compound (VIII) to obtain β-D-(1,4)-mannuronate oligosaccharide (IX).

Description

β-D-(1,4)-甘露糖醛酸寡糖及其中间体的制备方法Preparation method of β-D-(1,4)-mannuronic acid oligosaccharide and its intermediate 技术领域Technical field
本发明属于有机化学合成领域,涉及β-D-(1,4)-甘露糖醛酸寡糖(二糖至二十糖)的制备方法。The invention belongs to the field of organic chemistry synthesis, and relates to a preparation method of β-D-(1,4)-mannuronic acid oligosaccharides (disaccharides to eicosanose).
背景技术Background technique
β-D-(1,4)-甘露糖醛酸寡糖广泛存在于天然产物中,具有促进植物根系生长、抑菌、促进人角质化细胞生成等作用,能够与Toll样受体2和4结合,显示免疫调节的作用(CN103275133A),β-D-(1,4)-甘露糖醛酸寡糖在治疗血管性痴呆方面也具有良好的疗效(CN106344593A)。2019年11月2日,国家药监局批准用于治疗轻至中度阿尔兹海默病的甘露特纳胶囊上市,其主要成分即为β-D-(1,4)-甘露糖醛酸寡糖及其衍生物。β-D-(1,4)-mannuronic acid oligosaccharides are widely present in natural products. They can promote the growth of plant roots, inhibit bacteria, and promote the production of human keratinocytes. It can interact with Toll- like receptors 2 and 4 Combined, it shows the effect of immunomodulation (CN103275133A), β-D-(1,4)-mannuronic acid oligosaccharide also has a good effect in the treatment of vascular dementia (CN106344593A). On November 2, 2019, the National Food and Drug Administration approved the listing of Manrutner Capsules for the treatment of mild to moderate Alzheimer’s disease, the main ingredient of which is β-D-(1,4)-mannuronic acid Oligosaccharides and their derivatives.
目前,β-D-(1,4)-甘露糖醛酸寡糖主要通过降解海藻酸钠获得(CN100508985C),降解制备工艺对于其纯度及杂质控制存在较大的挑战,急需开发一种高效、操作简洁和能够精确控制的制备工艺。有文献报道运用固相合成法(WO2012138698)或液相合成法(Codée,Jeroen D.C,van den Bos,Leendert J,de Jong,Ana-Rae,et al.The Stereodirecting Effect of the Glycosyl C5-Carboxylate Ester:Stereoselective Synthesis of β-Mannuronic Acid Alginates[J].Journal of Organic Chemistry,74(1):38-47)制备β-D-(1,4)-甘露糖醛酸寡糖的衍生物,其中固相合成法成本高、对设备要求高,不易工业化生产。另外,现有液相合成法存在合成效率低下,脱除保护基比较繁琐等问题,不易工业化生产。因此,开发研究一种新型、高效和过程可控的β-D-(1,4)-甘露糖醛酸寡糖的制备方法,具有重要的应用价值和经济价值。At present, β-D-(1,4)-mannuronic acid oligosaccharides are mainly obtained by degrading sodium alginate (CN100508985C). The degradation preparation process presents greater challenges to its purity and impurity control. There is an urgent need to develop an efficient, Simple operation and precise control of the preparation process. There are reports in the literature using solid-phase synthesis (WO2012138698) or liquid-phase synthesis (Codée, Jeroen DC, van den Bos, Leendert J, de Jong, Ana-Rae, et al. The Stereodirecting Effect of the Glycosyl C5-Carboxylate Ester: Stereoselective Synthesis of β-Mannuronic Acid Alginates[J].Journal of Organic Chemistry,74(1):38-47) Preparation of β-D-(1,4)-mannuronic acid oligosaccharide derivatives, in which the solid phase The synthesis method has high cost, high equipment requirements, and is not easy to industrialize production. In addition, the existing liquid-phase synthesis method has problems such as low synthesis efficiency and complicated removal of protective groups, which is not easy for industrial production. Therefore, the development and research of a new, efficient and process-controllable preparation method of β-D-(1,4)-mannuronic acid oligosaccharide has important application value and economic value.
发明内容Summary of the invention
本发明的第一个方面,提供一种β-D-(1,4)-甘露糖醛酸寡糖的制备方 法,可以经济、高效地制备高纯度的β-D-(1,4)-甘露糖醛酸寡糖。该方法包括将化合物V和化合物VII进行偶联反应并选择性脱除保护基R 3生成化合物VIII; The first aspect of the present invention provides a method for preparing β-D-(1,4)-mannuronic acid oligosaccharides, which can economically and efficiently prepare high-purity β-D-(1,4)- Mannouronic acid oligosaccharides. The method includes coupling compound V and compound VII and selectively removing the protecting group R 3 to generate compound VIII;
Figure PCTCN2021094459-appb-000001
Figure PCTCN2021094459-appb-000001
以及任选地,将化合物VIII一次性脱除保护基R 2生成如式IX所示的β-D-(1,4)-甘露糖醛酸寡糖; And optionally, removing the protecting group R 2 of compound VIII at one time to generate β-D-(1,4)-mannuronic acid oligosaccharide as shown in formula IX;
Figure PCTCN2021094459-appb-000002
Figure PCTCN2021094459-appb-000002
其中,m选自2-18的整数;n和n’各自独立地选自0-8的整数;R 1选自C 1-8烷基、任选地被C 1-8烷基取代的C 6-14芳基;R 2为通过钯炭催化的氢化反应或钯炭催化的氧化反应可以脱除的羟基保护基;R 3为通过钯炭催化的氢化反应或钯炭催化的氧化反应不可以脱除的羟基保护基。 Wherein, m is selected from an integer of 2-18; n and n'are each independently selected from an integer of 0-8; R 1 is selected from C 1-8 alkyl, optionally substituted by C 1-8 alkyl 6-14 aryl group; R 2 is a hydroxyl protecting group that can be removed by hydrogenation reaction catalyzed by palladium-carbon or oxidation reaction catalyzed by palladium-carbon ; R 3 is hydrogenation reaction catalyzed by palladium-carbon or oxidation reaction catalyzed by palladium-carbon Removed hydroxyl protecting group.
特别地,本发明可以实现以经济易得的1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖(式X)为原料,制备中间体化合物I、II和III;然后将中间体化合物II和III偶联成寡糖受体化合物V,将中间体化合物I和II偶联成寡糖供体化合物VII;再将化合物V和化合物VII偶联成寡糖化合物VIII,脱除保护基得到最终产物化合物IX,即β-D-(1,4)-甘露糖醛酸寡糖。本发明为合成聚合度为2到20的β-D-(1,4)-甘露糖醛酸寡糖化合物提供了经济高效的解决方案,与降解海藻酸钠等提取制备寡糖混合物的工艺相比较,此方案可获得单一聚合度、高纯度的寡糖,为进一步研究单一聚合度寡糖的药理生物活性奠定了坚实的基础。In particular, the present invention can realize the preparation of intermediate compounds I, II, and 1,2,3,4,6-Penta-O-acetyl-D-mannanose (formula X), which are economically and easily available III; Then the intermediate compounds II and III are coupled to form an oligosaccharide acceptor compound V, and the intermediate compounds I and II are coupled to form an oligosaccharide donor compound VII; then compound V and compound VII are coupled to form an oligosaccharide compound VIII, the protective group is removed to obtain the final product compound IX, which is β-D-(1,4)-mannuronic acid oligosaccharide. The present invention provides an economical and efficient solution for the synthesis of β-D-(1,4)-mannuronic acid oligosaccharide compounds with a degree of polymerization of 2 to 20, which is comparable to the process of extracting and preparing oligosaccharide mixtures such as degrading sodium alginate. In comparison, this scheme can obtain oligosaccharides with a single degree of polymerization and high purity, which lays a solid foundation for further research on the pharmacological and biological activities of oligosaccharides with a single degree of polymerization.
本发明的第二个方面,提供了合成β-D-(1,4)-甘露糖醛酸寡糖的关键中间体化合物I、化合物II、化合物III、化合物V、化合物VII和化合物VIII, 结构式如下图所示:The second aspect of the present invention provides the key intermediate compound I, compound II, compound III, compound V, compound VII and compound VIII for the synthesis of β-D-(1,4)-mannuronic acid oligosaccharides, with structural formula As shown below:
Figure PCTCN2021094459-appb-000003
Figure PCTCN2021094459-appb-000003
其中,in,
R 1选自C 1-8烷基、任选地被C 1-8烷基取代的C 6-14芳基;优选地,R 1选自苯基、邻甲苯基、对甲基苯基、4-叔丁基-2-甲基苯基、2,4-二叔丁基苯基、甲基或乙基; R 1 is selected from C 1-8 alkyl, C 6-14 aryl optionally substituted by C 1-8 alkyl; preferably, R 1 is selected from phenyl, o-tolyl, p-methylphenyl, 4-tert-butyl-2-methylphenyl, 2,4-di-tert-butylphenyl, methyl or ethyl;
R 2为通过钯炭催化的氢化反应可以脱除的羟基保护基;优选地,R 2选自C 6-14芳基甲基或烯丙基,所述C 6-14芳基甲基任选地被C 1-8烷基、C 1-8烷氧基、卤素取代;更优选地,R 2选自苄基、对甲氧苄基、萘甲基、烯丙基;最优选地,R 2选自苄基; R 2 is a hydroxyl protecting group that can be removed by a hydrogenation reaction catalyzed by palladium on carbon; preferably, R 2 is selected from C 6-14 arylmethyl or allyl, and the C 6-14 arylmethyl optionally Is substituted by C 1-8 alkyl, C 1-8 alkoxy, halogen; more preferably, R 2 is selected from benzyl, p-methoxybenzyl, naphthylmethyl, and allyl; most preferably, R 2 is selected from benzyl;
R 3为通过钯炭催化的氢化反应不可以脱除的羟基保护基;优选地,R 3选自C 1-8烷基酰基、C 1-8烷氧基酰基、C 6-14芳基酰基、三(C 1-8烷基)甲硅烷基、9-芴基甲氧基甲酰基、三(C 6-14芳基)甲基;其中C 1-8烷基酰基和C 1-8烷氧基酰基中的C 1-8烷基中的任一碳原子可以任选地被氧代;更优选地,R 3选自乙酰基、乙酰丙酰基、三甲基硅基、叔丁基二甲基硅基、苯甲酰基、9-芴基甲氧基甲酰基、或三苯甲基;最优选地,R 3选自乙酰丙酰基; R 3 is a hydroxyl protecting group that cannot be removed by hydrogenation reaction catalyzed by palladium-carbon; preferably, R 3 is selected from C 1-8 alkyl acyl, C 1-8 alkoxy acyl, C 6-14 aryl acyl , Tris (C 1-8 alkyl) silyl, 9-fluorenyl methoxy formyl, tris (C 6-14 aryl) methyl; wherein C 1-8 alkyl acyl and C 1-8 alkane Any carbon atom in the C 1-8 alkyl group in the oxyacyl group may be optionally oxo; more preferably, R 3 is selected from the group consisting of acetyl, levulinyl, trimethylsilyl, tert-butyl di Methylsilyl, benzoyl, 9-fluorenylmethoxyformyl, or trityl; most preferably, R 3 is selected from levulinyl;
R 4选自H、C 1-8烷基、C 6-14芳基; R 4 is selected from H, C 1-8 alkyl, C 6-14 aryl;
X选自氟、氯、溴、碘;X is selected from fluorine, chlorine, bromine, and iodine;
m选自2-18的整数;优选地,m选自2、3、4、5、6、7、8、9、10、 11、12、13、14、15、16、17或18;m is selected from an integer of 2-18; preferably, m is selected from 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18;
n和n’各自独立地选自0-8的整数;优选地,n和n’各自独立地选自0、1、2、3、4、5、6、7或8。n and n'are each independently selected from an integer of 0-8; preferably, n and n'are each independently selected from 0, 1, 2, 3, 4, 5, 6, 7, or 8.
附图说明Description of the drawings
附图1为化合物VIII与化合物IX的通用合成路线。Figure 1 shows the general synthetic route of compound VIII and compound IX.
附图2为化合物IX-1与化合物IX-2的合成路线。Figure 2 shows the synthetic route of compound IX-1 and compound IX-2.
附图3为化合物IX-3与化合物IX-4的合成路线。Figure 3 shows the synthetic route of compound IX-3 and compound IX-4.
附图4为化合物IX-5的合成路线。Figure 4 shows the synthetic route of compound IX-5.
具体实施方式Detailed ways
除非另有说明,本文中提到的术语“烷基”可以是直链或支链的饱和烃基,比如甲基,乙基,丙基,丁基,辛基,异丙基,叔丁基,仲戊基和类似基团。烷基可以是未取代或被一个或多个取代基(比如,卤素,烷氧基,芳基,芳烷基,芳烷氧基和类似基团)所取代的。C 1-n烷基(其中n是整数)是指含有1-n个碳原子的烷基,例如1-18个碳原子,1-12个碳原子、1-10个碳原子、1-8个碳原子、1-6个碳原子、1-4个碳原子,等等。 Unless otherwise specified, the term "alkyl" mentioned herein can be a linear or branched saturated hydrocarbon group, such as methyl, ethyl, propyl, butyl, octyl, isopropyl, tert-butyl, Sec-pentyl and similar groups. The alkyl group may be unsubstituted or substituted with one or more substituents (for example, halogen, alkoxy, aryl, aralkyl, aralkoxy, and the like). C 1-n alkyl (where n is an integer) refers to an alkyl group containing 1-n carbon atoms, for example, 1-18 carbon atoms, 1-12 carbon atoms, 1-10 carbon atoms, 1-8 Carbon atoms, 1-6 carbon atoms, 1-4 carbon atoms, etc.
术语“芳基”是指具有单环(比如苯基)或稠环(比如萘基或蒽基)的单价不饱和芳香族基团,可选地被卤素(包括氟、氯、溴、碘),烷基,芳烷基,烷氧基,芳烷氧基和类似基团等取代基取代。C 6-n芳基(其中n是整数)是指具有6至n个碳原子的芳基,例如苯基、萘基、蒽基,或其任选取代的基团。 The term "aryl" refers to a monovalent unsaturated aromatic group having a single ring (such as phenyl) or a condensed ring (such as naphthyl or anthracenyl), optionally halogenated (including fluorine, chlorine, bromine, iodine) , Alkyl, aralkyl, alkoxy, aralkoxy and similar substituents are substituted. The C 6-n aryl group (wherein n is an integer) refers to an aryl group having 6 to n carbon atoms, such as phenyl, naphthyl, anthryl, or an optionally substituted group thereof.
本发明的第一个方面涉及一种制备如式(VIII)或式(IX)所示的β-D-(1,4)-甘露糖醛酸寡糖的方法,The first aspect of the present invention relates to a method for preparing β-D-(1,4)-mannuronic acid oligosaccharides represented by formula (VIII) or formula (IX),
Figure PCTCN2021094459-appb-000004
Figure PCTCN2021094459-appb-000004
包括:include:
将化合物V和化合物VII进行偶联反应并选择性脱除保护基R 3生成化合物VIII; Compound V and compound VII are subjected to a coupling reaction and the protective group R 3 is selectively removed to generate compound VIII;
Figure PCTCN2021094459-appb-000005
Figure PCTCN2021094459-appb-000005
以及任选地,将化合物VIII一次性脱除保护基R 2生成如式IX所示的β-D-(1,4)-甘露糖醛酸寡糖; And optionally, removing the protecting group R 2 of compound VIII at one time to generate β-D-(1,4)-mannuronic acid oligosaccharide as shown in formula IX;
其中,m选自2-18的整数;n和n’各自独立地选自0-8的整数;R 1选自C 1-8烷基、任选地被C 1-8烷基取代的C 6-14芳基;R 2为通过钯炭催化的氢化反应可以脱除的羟基保护基;R 3为通过钯炭催化的氢化反应不可以脱除的羟基保护基。 Wherein, m is selected from an integer of 2-18; n and n'are each independently selected from an integer of 0-8; R 1 is selected from C 1-8 alkyl, optionally substituted by C 1-8 alkyl 6-14 aryl group; R 2 is a hydroxy protecting group that can be removed by hydrogenation catalyzed by palladium on carbon; R 3 is a hydroxy protecting group that cannot be removed by hydrogenation catalyzed by palladium on carbon.
上述偶联反应在大位阻有机碱、二苯基亚砜和磺酸酐催化剂存在下进行;再依次脱除4位的羟基保护基R 3和其它位置的羟基保护基R 2,得到如IX所示的β-D-(1,4)-甘露糖醛酸寡糖化合物。优选地,所述磺酸酐催化剂选自甲磺酸酐、三氟甲磺酸酐或对甲苯磺酸酐。 The above coupling reaction is carried out in the presence of a large sterically hindered organic base, diphenyl sulfoxide and sulfonic anhydride catalyst; and then the hydroxyl protecting group R 3 at the 4-position and the hydroxyl protecting group R 2 at other positions are successively removed to obtain as shown in IX The β-D-(1,4)-mannuronic acid oligosaccharide compound shown. Preferably, the sulfonic anhydride catalyst is selected from methanesulfonic anhydride, trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride.
在本发明的一个实施方案中,提供了合成化合物V的方法,包括:In one embodiment of the present invention, a method for synthesizing compound V is provided, including:
Figure PCTCN2021094459-appb-000006
Figure PCTCN2021094459-appb-000006
将中间体化合物II和中间体化合物III溶解在适当有机溶剂中,加入干燥的分子筛,氮气或氩气保护,适当的温度下,加入磺酸催化剂,偶联反应生成1,4-糖苷键,然后选择性脱除4位羟基保护基,得到化合物IV;将化合物IV与化合物II重复进行上述偶联反应和选择性脱除4位羟基保护基R 3的步骤,任选地再将得到的化合物继续重复进行上述偶联反应和脱保护基的步骤,直至得到化合物V。 Dissolve Intermediate Compound II and Intermediate Compound III in a suitable organic solvent, add dry molecular sieves, protected by nitrogen or argon, add a sulfonic acid catalyst at a suitable temperature, and generate 1,4-glycosidic bonds in the coupling reaction. Selectively remove the 4-position hydroxyl protecting group to obtain compound IV; repeat the coupling reaction of compound IV and compound II and the steps of selectively removing the 4-position hydroxyl protecting group R 3 , and optionally continue the obtained compound Repeat the steps of coupling reaction and deprotection until compound V is obtained.
在本发明的一个优选实施方案中,化合物V的合成中所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙醚、无水N,N-二甲基甲酰胺、无水N,N-二甲基乙酰胺、无水甲苯或无水二甲亚砜,优选无水二氯甲烷;所述磺酸催化剂选自:甲磺酸、三氟甲磺酸、对甲苯磺酸或三氟甲磺酸三甲基硅酯,优选三氟甲磺酸三甲基硅酯;所述用于脱除4位羟基保护基的试剂优选醋酸肼,醋酸肼的摩尔当量为3-8eq,优选为3-5.5eq,例如4.3eq。In a preferred embodiment of the present invention, the organic solvent in the synthesis of compound V is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ether, anhydrous N,N-dimethylformamide, anhydrous N,N-dimethylacetamide, anhydrous toluene or anhydrous dimethylsulfoxide, preferably anhydrous dichloromethane; the sulfonic acid catalyst is selected from: methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid Or trimethylsilyl trifluoromethanesulfonate, preferably trimethylsilyl trifluoromethanesulfonate; the reagent for removing the 4-position hydroxyl protecting group is preferably hydrazine acetate, and the molar equivalent of hydrazine acetate is 3-8eq , Preferably 3-5.5eq, for example 4.3eq.
在本发明的一个实施方案中,提供了合成化合物VII的方法,包括:In one embodiment of the present invention, a method for synthesizing compound VII is provided, including:
Figure PCTCN2021094459-appb-000007
Figure PCTCN2021094459-appb-000007
将化合物I和化合物II溶解在适当有机溶剂中,加入干燥的分子筛,氮气或氩气保护,适当的温度下,加入磺酸催化剂,偶联反应生成1,4-糖苷键,然后选择性地脱除4位羟基保护基R 3,得到化合物VI;将化合物VI与化合物II重复进行上述偶联反应和选择性脱除4位保护基R 3的步骤;任选地再将得到的化合物继续重复进行上述偶联反应和脱保护基的 步骤,直至得到化合物VII。 Dissolve compound I and compound II in a suitable organic solvent, add dry molecular sieve, nitrogen or argon protection, add a sulfonic acid catalyst at a suitable temperature, the coupling reaction generates 1,4-glycosidic bonds, and then selectively remove Remove the 4-position hydroxy protecting group R 3 to obtain compound VI; repeat the above coupling reaction and selectively remove the 4-position protecting group R 3 steps of compound VI and compound II; optionally continue repeating the obtained compound The steps of coupling reaction and deprotection are mentioned above until compound VII is obtained.
在本发明的一个优选实施方案中,化合物VII的合成中所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙醚、无水N,N-二甲基甲酰胺、无水N,N-二甲基乙酰胺、无水甲苯或无水二甲亚砜,优选无水二氯甲烷;所述磺酸催化剂选自:甲磺酸、三氟甲磺酸、对甲苯磺酸或三氟甲磺酸三甲基硅酯;所述磺酸催化剂优选三氟甲磺酸三甲基硅酯;所述用于脱除4位羟基保护基的试剂优选醋酸肼。In a preferred embodiment of the present invention, the organic solvent in the synthesis of compound VII is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ether, anhydrous N,N-dimethylformamide, anhydrous N,N-dimethylacetamide, anhydrous toluene or anhydrous dimethylsulfoxide, preferably anhydrous dichloromethane; the sulfonic acid catalyst is selected from: methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid Or trimethylsilyl trifluoromethanesulfonate; the sulfonic acid catalyst is preferably trimethylsilyl trifluoromethanesulfonate; the reagent for removing the 4-position hydroxyl protecting group is preferably hydrazine acetate.
在本发明的一个实施方案中,提供了合成化合物IX的方法,包括:In one embodiment of the present invention, a method for synthesizing compound IX is provided, including:
Figure PCTCN2021094459-appb-000008
Figure PCTCN2021094459-appb-000008
将化合物V和化合物VII溶解在适当的有机溶剂中,加入干燥的分子筛,氮气或氩气保护,适当的温度下,加入大位阻有机碱、二苯基亚砜和磺酸酐催化,偶联反应生成1,4-糖苷键,再选择性脱除4位羟基的保护基R 3得化合物VIII;向化合物VIII中加入钯炭(钯含量5%-10%),氢化脱除化合物VIII的所有R 2保护基,得到β-D-(1,4)-甘露糖醛酸寡糖化合物IX。 Dissolve compound V and compound VII in a suitable organic solvent, add dry molecular sieve, protected by nitrogen or argon, at a suitable temperature, add large hindered organic base, diphenyl sulfoxide and sulfonic anhydride to catalyze the coupling reaction Generate 1,4-glycosidic bonds, and then selectively remove the protective group R 3 of the 4-position hydroxyl group to obtain compound VIII; add palladium on carbon (palladium content 5%-10%) to compound VIII, and remove all R from compound VIII by hydrogenation 2 protecting groups to obtain β-D-(1,4)-mannuronic acid oligosaccharide compound IX.
在本发明的一个优选实施方案中,化合物IX的合成中所述化合物V和化合物VII的摩尔比为1:0.9;所述偶联反应的溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙醚、无水N,N-二甲基甲酰胺、无水N,N-二甲基乙酰胺、无水甲苯或无水二甲亚砜,优选无水二氯甲烷;所述大位阻有机碱选自:1,8-二氮杂二环十一碳-7-烯、2,6-二叔丁基吡啶或2,4,6-三叔丁基嘧啶,优选2,6-二叔丁基吡啶;所述磺酸酐催化剂选自:甲磺酸酐、三氟甲磺酸酐或对甲苯磺酸酐,优选三氟甲磺酸酐;磺酸酐的摩尔当量优选为0.05eq;反应温度优选为-60℃;用于脱除4位羟基保护基的试剂优选为醋酸肼,其摩尔当量优选为4.3eq;脱除保护基的温度优选为25℃。In a preferred embodiment of the present invention, the molar ratio of compound V and compound VII in the synthesis of compound IX is 1:0.9; the solvent for the coupling reaction is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, Anhydrous ether, anhydrous N,N-dimethylformamide, anhydrous N,N-dimethylacetamide, anhydrous toluene or anhydrous dimethyl sulfoxide, preferably anhydrous dichloromethane; The hindered organic base is selected from: 1,8-diazabicycloundec-7-ene, 2,6-di-tert-butylpyridine or 2,4,6-tri-tert-butylpyrimidine, preferably 2,6- Di-tert-butylpyridine; the sulfonic anhydride catalyst is selected from: methanesulfonic anhydride, trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride, preferably trifluoromethanesulfonic anhydride; the molar equivalent of sulfonic anhydride is preferably 0.05eq; the reaction temperature is preferably -60°C; the reagent used to remove the protecting group of the 4-hydroxyl group is preferably hydrazine acetate, and its molar equivalent is preferably 4.3 eq; the temperature for removing the protecting group is preferably 25°C.
上文中所使用的起始化合物式I和式II可以分别从式X化合物获得。The starting compounds of Formula I and Formula II used above can be obtained from the compound of Formula X, respectively.
式X化合物为1-5取代的吡喃甘露糖,其中的取代基可以为C 1-C 6酰基,例如甲酰基、乙酰基、丙酰基。式X化合物的一个实例为1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖。 The compound of formula X is 1-5 substituted mannanose, wherein the substituent may be a C 1 -C 6 acyl group, such as formyl, acetyl, and propionyl. An example of a compound of formula X is 1,2,3,4,6-penta-O-acetyl-D-mannanose.
在本发明的一个优选实施方案中,从简单易得的原料1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖(式X所示的化合物)为例,总体的反应路线如下:In a preferred embodiment of the present invention, 1,2,3,4,6-penta-O-acetyl-D-mannanose (compound represented by formula X), which is a simple and easily available raw material, is taken as an example, The overall reaction route is as follows:
Figure PCTCN2021094459-appb-000009
Figure PCTCN2021094459-appb-000009
其中R 5为C 1-8的酰基,优选为乙酰基。 Wherein R 5 is a C 1-8 acyl group, preferably an acetyl group.
在本发明的一个实施方案中,提供了合成中间体化合物I的方法,包括:In one embodiment of the present invention, a method for synthesizing intermediate compound I is provided, including:
Figure PCTCN2021094459-appb-000010
Figure PCTCN2021094459-appb-000010
步骤1:1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖与异头碳保护剂R 1SH反应,然后再进行碱性水解反应,得化合物A; Step 1: 1,2,3,4,6-penta-O-acetyl-D-mannanose reacts with the anomeric carbon protective agent R 1 SH, and then performs an alkaline hydrolysis reaction to obtain compound A;
步骤2:选择性地保护化合物A的2位和3位的羟基,得到化合物B;Step 2: Selectively protect the 2 and 3 hydroxyl groups of compound A to obtain compound B;
步骤3:将化合物B的6位的羟基氧化为羧基,然后使该羧基酯化得到化合物I。Step 3: Oxidize the hydroxyl group at the 6-position of compound B to a carboxyl group, and then esterify the carboxyl group to obtain compound I.
在一个优选的实施方案中,该方法包括:In a preferred embodiment, the method includes:
步骤1.在干燥的有机溶剂中,以1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖为原料,在酸性催化剂存在下,在适当的温度下搅拌,氮气或氩气保护,加入适当的异头碳保护剂R 1SH进行反应,然后再进行碱水解,得化合物A; Step 1. In a dry organic solvent, using 1,2,3,4,6-penta-O-acetyl-D-mannanose as a raw material, stirring at an appropriate temperature in the presence of an acidic catalyst, Protected by nitrogen or argon, add a suitable anomeric carbon protective agent R 1 SH for reaction, and then conduct alkaline hydrolysis to obtain compound A;
步骤2.在路易酸催化下,选择适当的羟基保护基,将化合物A的4位和6位的羟基选择性保护,然后再选择性保护2位和3位的羟基,最后再选择性脱除4位和6位的保护基得到化合物B; Step 2. Under the catalysis of Lewis acid, select an appropriate hydroxyl protecting group to selectively protect the 4 and 6 hydroxyl groups of compound A, then selectively protect the 2 and 3 hydroxyl groups, and finally selectively remove them Protecting groups at positions 4 and 6 give compound B;
步骤3.在有机溶剂中,向化合物B中加入氧化剂,选择性氧化化合物B的6位羟基为羧基,再在碱性条件下,在适当的温度和溶剂中,和烷基化试剂反应成酯得到化合物I。 Step 3. In an organic solvent, add an oxidizing agent to compound B to selectively oxidize the 6-position hydroxyl group of compound B to a carboxyl group, and then react with an alkylating agent to form an ester under alkaline conditions at an appropriate temperature and solvent. Compound I is obtained.
在一个更优选的实施方案中,中间体化合物I的合成采用一锅两步反应,中间体无需分离纯化。其中,步骤1中所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水甲苯、无水N,N-二甲基甲酰胺或无水N,N-二甲基乙酰胺;所述适当的温度为0-25℃,优选0-5℃;所述酸性催化剂选自:三氟化硼乙醚、乙酰氯或氯化氢气体,优选三氟化硼乙醚;三氟化硼乙醚的摩尔当量优选为0.1eq;所述碱选自:乙醇钠、乙醇钾、乙醇镁、甲醇钠,甲醇钾或甲醇镁,优选甲醇钠;甲醇钠的摩尔当量优选为0.1eq;所述碱水解的溶剂选自:甲醇、乙醇或四氢呋喃,优选甲醇;所述反应中加入的异头碳保护剂选自:苯硫酚、邻甲苯硫酚、对甲基苯硫酚、4-叔丁基-2-甲基苯硫酚、2,4-二叔丁基苯硫酚、甲硫醇或乙硫醇,优选对甲基苯硫酚;异头碳保护剂的摩尔当量优选为1.05eq。In a more preferred embodiment, the synthesis of the intermediate compound I adopts a one-pot two-step reaction, and the intermediate does not need to be separated and purified. Wherein, the organic solvent in step 1 is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous toluene, anhydrous N,N-dimethylformamide or anhydrous N,N-dimethylacetamide; The appropriate temperature is 0-25°C, preferably 0-5°C; the acid catalyst is selected from: boron trifluoride ether, acetyl chloride or hydrogen chloride gas, preferably boron trifluoride ether; moles of boron trifluoride ether The equivalent is preferably 0.1eq; the base is selected from: sodium ethoxide, potassium ethoxide, magnesium ethoxide, sodium methoxide, potassium methoxide or magnesium methoxide, preferably sodium methoxide; the molar equivalent of sodium methoxide is preferably 0.1eq; the solvent for the alkali hydrolysis Selected from: methanol, ethanol or tetrahydrofuran, preferably methanol; the anomeric carbon protective agent added in the reaction is selected from: thiophenol, o-toluenethiol, p-methylthiophenol, 4-tert-butyl-2- Methyl thiophenol, 2,4-di-tert-butyl thiophenol, methyl mercaptan or ethyl mercaptan, preferably p-methyl thiophenol; the molar equivalent of the anomeric carbon protecting agent is preferably 1.05 eq.
其中,步骤2中所述用于化合物A的4位和6位保护的保护剂选自:苯二甲缩醛,对甲氧基苯二缩醛或2,2-二甲氧基丙烷(丙酮叉),优选苯二甲缩醛;苯二甲缩醛的摩尔当量优选为0.9eq;所述路易酸催化剂选自:对甲苯磺酸、三氟甲磺酸、三氯化铝和三氯化铁,优选三氯化铁;所述用于保护化合物A的2位和3位的羟基的保护剂选自溴苄、氯苄、对甲氧基溴苄、对甲氧基氯苄或烯丙基溴,优选溴苄;溴苄的当量优选为1.9eq。Wherein, the protecting agent used for protecting the 4-position and 6-position of compound A in step 2 is selected from: phthalic acetal, p-methoxy phthalic acetal or 2,2-dimethoxypropane (acetone Fork), preferably phthalic acetal; the molar equivalent of phthalic acetal is preferably 0.9eq; the Lewis acid catalyst is selected from: p-toluenesulfonic acid, trifluoromethanesulfonic acid, aluminum trichloride and trichloride Iron, preferably iron trichloride; the protective agent used to protect the 2-position and 3-position hydroxyl groups of compound A is selected from the group consisting of benzyl bromide, benzyl chloride, p-methoxybenzyl bromide, p-methoxybenzyl chloride or allyl Base bromide, preferably benzyl bromide; the equivalent of benzyl bromide is preferably 1.9 eq.
其中,步骤3中所述氧化剂选自:四甲基哌啶氮氧化物、次氯酸钠、 溴化钾、双氧水、叔丁基过氧化氢或二乙酸碘苯,优选四甲基哌啶氮氧化物或二乙酸碘苯;四甲基哌啶氮氧化物的摩尔当量优选为0.2eq,或者二乙酸碘苯的摩尔当量优选为2.5eq;所述有机溶剂选自:二氯甲烷、乙腈、水、四氢呋喃、N,N-二甲基甲酰胺或N,N-二甲基乙酰胺中的任一种或多种,优选选自:乙腈-水混合溶剂(乙腈与水的体积比为约5:1-1:5)、四氢呋喃-水混合溶剂(四氢呋喃与水的体积比为约5:1-1:5)或二氯甲烷-水混合溶剂(二氯甲烷与水的体积比为约5:1-1:5),更优选二氯甲烷-水混合溶剂(二氯甲烷与水的体积比为约1:2);所述氧化反应的温度为0℃到25℃,优选的温度为25℃;所述碱选自:碳酸钾、碳酸铯、碳酸钠、碳酸钙、碳酸银、三乙胺或二异丙基乙胺,优选碳酸钾或三乙胺;碱的摩尔当量优选为0.5eq至3eq,更优选摩尔当量为1.5eq的碳酸钾或摩尔当量为1eq的三乙胺;所述烷基化试剂选自:溴苄、氯苄、对甲氧基溴苄、对甲氧基氯苄或烯丙基溴,优选溴苄;所述烷基化反应的溶剂选自:四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、丙酮或乙腈,优选丙酮;所述烷基化反应的温度为25℃到100℃,优选的温度为30℃。Wherein, the oxidant in step 3 is selected from: tetramethylpiperidine nitroxide, sodium hypochlorite, potassium bromide, hydrogen peroxide, tert-butyl hydroperoxide or iodobenzene diacetate, preferably tetramethylpiperidine nitroxide or Iodobenzene diacetate; the molar equivalent of tetramethylpiperidine nitrogen oxide is preferably 0.2eq, or the molar equivalent of iodobenzene diacetate is preferably 2.5eq; the organic solvent is selected from: dichloromethane, acetonitrile, water, tetrahydrofuran , N,N-dimethylformamide or any one or more of N,N-dimethylacetamide, preferably selected from: acetonitrile-water mixed solvent (the volume ratio of acetonitrile to water is about 5:1 -1:5), tetrahydrofuran-water mixed solvent (the volume ratio of tetrahydrofuran to water is about 5:1 to 1:5) or dichloromethane-water mixed solvent (the volume ratio of dichloromethane to water is about 5:1 -1:5), more preferably a dichloromethane-water mixed solvent (the volume ratio of dichloromethane to water is about 1:2); the temperature of the oxidation reaction is 0°C to 25°C, and the preferred temperature is 25°C The base is selected from: potassium carbonate, cesium carbonate, sodium carbonate, calcium carbonate, silver carbonate, triethylamine or diisopropylethylamine, preferably potassium carbonate or triethylamine; the molar equivalent of the base is preferably 0.5eq to 3eq, more preferably 1.5eq of potassium carbonate or 1eq of triethylamine; the alkylating reagent is selected from: benzyl bromide, benzyl chloride, p-methoxybenzyl bromide, and p-methoxybenzyl chloride Or allyl bromide, preferably benzyl bromide; the solvent for the alkylation reaction is selected from: tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, acetone or acetonitrile, preferably acetone; The temperature of the alkylation reaction is 25°C to 100°C, and the preferred temperature is 30°C.
在本发明的一个实施方案中,提供了合成中间体化合物II的方法,包括:In one embodiment of the present invention, a method for synthesizing intermediate compound II is provided, including:
Figure PCTCN2021094459-appb-000011
Figure PCTCN2021094459-appb-000011
步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
步骤2:选择性地脱除化合物D的异头碳保护基-SR 1,得到化合物E; Step 2: Selectively remove the anomeric carbon protecting group -SR 1 of compound D to obtain compound E;
步骤3:在碱性条件下,将化合物E与CX 3CN或CX 3C(=NR 4)X反应得到化合物II。 Step 3: Under basic conditions, compound E is reacted with CX 3 CN or CX 3 C(=NR 4 )X to obtain compound II.
在一个优选的实施方案中,该方法包括:In a preferred embodiment, the method includes:
步骤1:在干燥的有机溶剂中,在碱性条件下,使用合适的保护剂将化合物I的4位羟基保护得到化合物D;Step 1: In a dry organic solvent, under alkaline conditions, use a suitable protective agent to protect the 4-hydroxyl of compound I to obtain compound D;
步骤2:选择性脱除化合物D的异头碳保护基-SR 1,得化合物E; Step 2: Selectively remove the anomeric carbon protecting group -SR 1 of compound D to obtain compound E;
步骤3:在干燥的有机溶剂中,在碱性条件下,将化合物E与CX 3CN或CX 3C(=NR 4)X(例如,三氯乙腈)反应得到化合物II。 Step 3: In a dry organic solvent, under alkaline conditions, compound E is reacted with CX 3 CN or CX 3 C(=NR 4 )X (for example, trichloroacetonitrile) to obtain compound II.
在一个更优选的实施方案中,中间体化合物II的合成采用一锅三步反应,中间体无需分离纯化。其中,步骤1中所述合适的保护剂选自乙酰氯、醋酸酐、三甲基氯硅烷、叔丁基二甲基氯硅烷、苯甲酰氯、氯甲酸-9-芴基甲酯、三苯基氯甲烷、乙酰丙酰氯或乙酰丙酸,优选乙酰丙酸;保护剂的摩尔当量优选为1.5eq;所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙酸乙酯、无水乙腈、无水甲苯、无水N,N-二甲基甲酰胺或无水N,N-二甲基乙酰胺,优选无水二氯甲烷;优选的反应温度为25℃;所述碱选自:无水碳酸钾、无水碳酸钠、三乙胺、N,N-对二甲基氨基吡啶或吡啶,优选N,N-对二甲基氨基吡啶;碱的摩尔当量优选为1.5eq。In a more preferred embodiment, the synthesis of the intermediate compound II adopts a one-pot three-step reaction, and the intermediate does not need to be separated and purified. Wherein, the suitable protective agent in step 1 is selected from acetyl chloride, acetic anhydride, trimethylchlorosilane, tert-butyldimethylchlorosilane, benzoyl chloride, 9-fluorenylmethyl chloroformate, triphenyl Methyl chloride, levulinyl chloride or levulinic acid, preferably levulinic acid; the molar equivalent of the protective agent is preferably 1.5eq; the organic solvent is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ethyl acetate, Anhydrous acetonitrile, anhydrous toluene, anhydrous N,N-dimethylformamide or anhydrous N,N-dimethylacetamide, preferably anhydrous dichloromethane; the preferred reaction temperature is 25°C; the alkali Selected from: anhydrous potassium carbonate, anhydrous sodium carbonate, triethylamine, N,N-p-dimethylaminopyridine or pyridine, preferably N,N-p-dimethylaminopyridine; the molar equivalent of the base is preferably 1.5eq .
其中,步骤2中所述用于脱除异头碳保护基的试剂选自N-氯代丁二酰亚胺或N-溴代丁二酰亚胺,优选N-溴代丁二酰亚胺;反应温度优选为25℃。Wherein, the reagent for removing the protective group of the anomeric carbon in step 2 is selected from N-chlorosuccinimide or N-bromosuccinimide, preferably N-bromosuccinimide ; The reaction temperature is preferably 25°C.
其中,步骤3中所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙酸乙酯、无水乙腈、无水甲苯、无水N,N-二甲基甲酰胺或无水N,N-二甲基乙酰胺,优选无水二氯甲烷;反应温度优选为0℃到10℃;所述碱选自:无水碳酸钾、无水碳酸钠、三乙胺、1,8-二氮杂双环[5.4.0]十一碳-7-烯、N,N-对二甲基氨基吡啶或吡啶,优选1,8-二氮杂双环[5.4.0]十一碳-7-烯;碱的摩尔当量优选为0.5eq。Wherein, the organic solvent in step 3 is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ethyl acetate, anhydrous acetonitrile, anhydrous toluene, anhydrous N,N-dimethylformamide or anhydrous N,N-dimethylacetamide, preferably anhydrous dichloromethane; the reaction temperature is preferably 0°C to 10°C; the base is selected from: anhydrous potassium carbonate, anhydrous sodium carbonate, triethylamine, 1,8 -Diazabicyclo[5.4.0]undec-7-ene, N,N-p-dimethylaminopyridine or pyridine, preferably 1,8-diazabicyclo[5.4.0]undec-7 -En; The molar equivalent of the base is preferably 0.5 eq.
在本发明的一个实施方案中,提供合成中间体化合物III的方法,包括:In one embodiment of the present invention, a method for synthesizing intermediate compound III is provided, including:
Figure PCTCN2021094459-appb-000012
Figure PCTCN2021094459-appb-000012
步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
步骤2:在碱性条件下,将化合物D与R 2OH反应,得到化合物F; Step 2: Under alkaline conditions, react compound D with R 2 OH to obtain compound F;
步骤3:选择性地脱除化合物F的4位羟基保护基R 3,得到化合物III。 Step 3: Selectively remove the protective group R 3 of the 4-hydroxyl group of compound F to obtain compound III.
在一个优选的实施方案中,该方法包括:In a preferred embodiment, the method includes:
步骤1.在干燥的有机溶剂中,在碱性条件下,使用合适的保护剂将化合物I的4位羟基保护得到化合物D; Step 1. In a dry organic solvent, under alkaline conditions, use a suitable protective agent to protect the 4-position hydroxyl group of compound I to obtain compound D;
步骤2.在干燥的有机溶剂中,在大位阻碱存在下,向化合物D中加入R 2OH,二苯基硫酚和磺酸酐催化剂,反应得到化合物F; Step 2. In a dry organic solvent, in the presence of a large hindered base, R 2 OH, diphenylthiophenol and sulfonic anhydride catalyst are added to compound D to react to obtain compound F;
步骤3.在有机溶剂中选择性地脱除化合物F的4位羟基保护基得化合物III。 Step 3. Selectively remove the protecting group of the 4-hydroxyl group of compound F in an organic solvent to obtain compound III.
在本发明的一个更优选的实施方案中,中间体化合物III的合成采用一锅三步法。其中,步骤1中所述合适的保护剂选自:乙酰氯、醋酸酐、三甲基氯硅烷、叔丁基二甲基氯硅烷、氯甲酸-9-芴基甲酯、苯甲酰氯、三苯基氯甲烷、乙酰丙酰氯或乙酰丙酸,优选乙酰丙酸;保护剂摩尔当量优选为1.5eq;所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙酸乙酯、无水乙腈、无水甲苯、无水N,N-二甲基甲酰胺或无水N,N-二甲基乙酰胺,优选无水二氯甲烷;反应温度优选为25℃;所述的碱选自:无水碳酸钾、无水碳酸钠、三乙胺、N,N-对二甲基氨基吡啶或吡啶,优选N,N-对二甲基氨基吡啶;碱的摩尔当量优选为1.5eq。In a more preferred embodiment of the present invention, the synthesis of intermediate compound III adopts a one-pot three-step method. Wherein, the suitable protective agent in step 1 is selected from: acetyl chloride, acetic anhydride, trimethylchlorosilane, tert-butyldimethylchlorosilane, 9-fluorenylmethyl chloroformate, benzoyl chloride, trimethylchlorosilane, Phenyl chloride, levulinyl chloride or levulinic acid, preferably levulinic acid; the molar equivalent of the protective agent is preferably 1.5eq; the organic solvent is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ethyl acetate, Anhydrous acetonitrile, anhydrous toluene, anhydrous N,N-dimethylformamide or anhydrous N,N-dimethylacetamide, preferably anhydrous dichloromethane; the reaction temperature is preferably 25°C; the alkali Selected from: anhydrous potassium carbonate, anhydrous sodium carbonate, triethylamine, N,N-p-dimethylaminopyridine or pyridine, preferably N,N-p-dimethylaminopyridine; the molar equivalent of the base is preferably 1.5eq .
其中,步骤2中所述有机溶剂选自:无水二氯甲烷、无水四氢呋喃、无水乙醚、无水N,N-二甲基甲酰胺、无水N,N-二甲基乙酰胺、无水甲苯或无水二甲亚砜,优选无水二氯甲烷;所述大位阻有机碱选自:1,8-二氮杂二环十一碳-7-烯、2,6-二叔丁基吡啶或2,4,6-三叔丁基嘧啶,优选2,6-二叔丁基吡啶;碱的摩尔当量优选为2.2eq;所述磺酸酐催化剂选自:甲磺酸酐、三氯甲磺酸酐、三溴甲磺酸酐、三氟甲磺酸酐或甲苯磺酸酐,优选三氟甲磺酸酐;三氟甲磺酸酐的摩尔当量优选为0.05eq;反应温度优选为-60℃。Wherein, the organic solvent in step 2 is selected from: anhydrous dichloromethane, anhydrous tetrahydrofuran, anhydrous ether, anhydrous N,N-dimethylformamide, anhydrous N,N-dimethylacetamide, Anhydrous toluene or anhydrous dimethyl sulfoxide, preferably anhydrous dichloromethane; the large sterically hindered organic base is selected from: 1,8-diazabicycloundec-7-ene, 2,6-di Tert-butylpyridine or 2,4,6-tri-tert-butylpyrimidine, preferably 2,6-di-tert-butylpyridine; the molar equivalent of the base is preferably 2.2eq; the sulfonic acid anhydride catalyst is selected from: methanesulfonic anhydride, three Chloromethanesulfonic anhydride, tribromomethanesulfonic anhydride, trifluoromethanesulfonic anhydride or toluenesulfonic anhydride is preferably trifluoromethanesulfonic anhydride; the molar equivalent of trifluoromethanesulfonic anhydride is preferably 0.05eq; and the reaction temperature is preferably -60°C.
其中,步骤3中所述有机溶剂为二氯甲烷和/或吡啶,优选二氯甲烷:吡啶=5:1(V/V);用于选择性地脱除化合物F的4位羟基保护基的试剂优选为醋酸肼,其当量优选为4.3eq。Wherein, the organic solvent in step 3 is dichloromethane and/or pyridine, preferably dichloromethane: pyridine=5:1 (V/V); it is used to selectively remove the 4-hydroxy protecting group of compound F The reagent is preferably hydrazine acetate, and its equivalent is preferably 4.3 eq.
在本发明的一个优选方案中,所述化合物I、化合物II和化合物III分 别为如下结构式所示的化合物I-1、II-1和III-1:In a preferred embodiment of the present invention, the compound I, compound II and compound III are respectively compounds I-1, II-1 and III-1 represented by the following structural formulas:
Figure PCTCN2021094459-appb-000013
Figure PCTCN2021094459-appb-000013
本发明的优点在于:The advantages of the present invention are:
本文所述的制备β-D-(1,4)-甘露糖醛酸寡糖(化合物IX)方法采用汇聚式的合成策略,通过全新的寡糖中间体化合物I、化合物II和化合物III,将寡糖供体(化合物VII)和寡糖受体(化合物V)组装成糖基数更高的寡糖化合物VIII,再一次性脱除化合物VIII中的保护基R 2,合成β-D-(1,4)-甘露糖醛酸寡糖(化合物IX)。与现有技术相比,本发明的制备方法更加简洁、经济、高效。 The method for preparing β-D-(1,4)-mannuronic acid oligosaccharides (Compound IX) described herein adopts a convergent synthesis strategy. Through the new oligosaccharide intermediates Compound I, Compound II and Compound III, The oligosaccharide donor (Compound VII) and the oligosaccharide acceptor (Compound V) are assembled into the oligosaccharide compound VIII with a higher number of sugar bases, and the protective group R 2 in compound VIII is removed at one time to synthesize β-D-(1 , 4)-Mannouronic acid oligosaccharide (Compound IX). Compared with the prior art, the preparation method of the present invention is more concise, economical and efficient.
实施例Example
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。The present invention will be further explained below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and not to limit the scope of the present invention. The experimental methods that do not indicate specific conditions in the following examples are usually in accordance with conventional conditions or in accordance with the conditions recommended by the manufacturer.
下面的实施例部分提供了β-D-(1,4)-甘露糖醛酸的二糖(化合物IX-1)、四糖(化合物IX-2)、三糖(化合物IX-3)、五糖(化合物IX-4)和七糖(化合物IX-5)的全合成方案进一步说明本发明,但本发明并不受其限制。The following example section provides the disaccharides (compound IX-1), tetrasaccharides (compound IX-2), trisaccharides (compound IX-3), pentasaccharides of β-D-(1,4)-mannuronic acid The total synthesis scheme of sugar (compound IX-4) and heptasaccharide (compound IX-5) further illustrates the present invention, but the present invention is not limited thereto.
实施例中的原料或试剂除特别说明以外,均市售可得。Unless otherwise specified, the raw materials or reagents in the examples are all commercially available.
实施例中的室温指20-30℃。The room temperature in the examples refers to 20-30°C.
实施例中的常压指1个大气压。The normal pressure in the examples refers to 1 atmosphere.
实施例中的水指去离子水。The water in the examples refers to deionized water.
缩略语的含义Meaning of acronyms
缩略语Abbreviations 含义meaning
TLCTLC 薄层色谱TLC
EAEA 乙酸乙酯Ethyl acetate
HexHex 己烷Hexane
DCMDCM 二氯甲烷Dichloromethane
TEMPOTEMPO 四甲基哌啶氮氧化物Tetramethylpiperidine Nitrogen Oxide
DICDIC 二异丙基碳二亚胺Diisopropylcarbodiimide
DMAPDMAP 二甲氨基吡啶Dimethylaminopyridine
NBS NBS 溴代琥珀酰亚胺Bromosuccinimide
DBUDBU 1,8-二氮杂二环十一碳-7-烯1,8-diazabicycloundec-7- ene
TTBPTTBP 2,4,6-三叔丁基吡啶2,4,6-Tri-tert-butylpyridine
Tf 2O Tf 2 O 三氟甲磺酸酐Trifluoromethanesulfonic anhydride
LevOHLevOH 乙酰丙酸Levulinic acid
TMSOTfTMSOTf 三氟甲磺酸三甲基硅酯Trimethylsilyl Trifluoromethanesulfonate
CNCCl 3 CNCCl 3 三氯乙腈Trichloroacetonitrile
minmin 分钟minute
mLmL 毫升Milliliters
mmolmmol 毫摩尔Millimoles
实施例1:化合物I-1的合成Example 1: Synthesis of compound I-1
第一步:称取1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖(19.5g,50.0mmol)置于500mL的茄型瓶中,加入无水二氯甲烷(150mL),溶液呈无色透明,在冰浴下,加入对甲苯硫酚(6.2g,50.0mmol),三氟化硼乙醚 溶液(12.7mL,100mmol)。冰浴下搅拌半小时后,室温下继续搅拌24小时,溶液由淡黄色变为粉红色。TLC(EA/Hex=1/2)检测原料消失,用饱和NaHCO 3溶液淬灭反应,分液漏斗分离出二氯甲烷层,减压蒸除溶剂,再加入200mL无水甲醇复溶,加入甲醇钠(256mg,4.7mmol),室温搅拌反应12小时,TLC(EA/Hex=1/2)检测原料反应完全,稀盐酸调pH至中性,减压蒸除溶剂,再加入二氯甲烷(100mL)和水(100mL),室温搅拌半小时,分液漏斗分出水层,减压蒸除水,得粗品化合物A-1直接用于下一步无需纯化。 Step 1: Weigh 1,2,3,4,6-penta-O-acetyl-D-mannanose (19.5g, 50.0mmol) into a 500mL eggplant-shaped bottle, add anhydrous dichloride Methane (150 mL), the solution was colorless and transparent, in an ice bath, p-toluene thiophenol (6.2 g, 50.0 mmol) and boron trifluoride ether solution (12.7 mL, 100 mmol) were added. After stirring for half an hour in an ice bath, stirring was continued for 24 hours at room temperature, and the solution changed from light yellow to pink. TLC (EA/Hex=1/2) detects the disappearance of the raw materials, quenches the reaction with saturated NaHCO 3 solution, separates the dichloromethane layer with a separatory funnel, evaporates the solvent under reduced pressure, and then adds 200 mL of anhydrous methanol for reconstitution, and then adds methanol Sodium (256mg, 4.7mmol), stirred at room temperature for 12 hours, TLC (EA/Hex=1/2) detected that the raw material had reacted completely, adjusted the pH to neutral with dilute hydrochloric acid, evaporated the solvent under reduced pressure, and added dichloromethane (100mL ) And water (100 mL), stirred at room temperature for half an hour, separated the aqueous layer with a separatory funnel, evaporated under reduced pressure to remove the water to obtain the crude compound A-1 directly used in the next step without purification.
第二步:将粗品化合物A-1(约47.3mmol)溶于200mL无水DMF中,加入PhCH(OMe) 2(7.9g,52.03mmol,1.1eq),对甲苯磺酸(899mg,4.7mmol,0.1eq),反应温度控制在50℃,减压反应2小时,TLC(CH 3OH/DCM=1/9)表明原料反应完全。将反应冷却至室温,冰浴下加入NaH(5.68g,141.9mmol,3.0eq)反应20min后,再加入BnBr(20.2g,118.3mmol,2.5eq),20分钟后撤去冰浴,室温搅拌12小时,TLC(EA/Hex=1/4)表明原料转化完全。在冰浴下用甲醇(10mL)将NaH淬灭,加入乙酸乙酯(200mL)稀释反应液,饱和食盐水(200mL)洗涤三次反应液,减压浓缩除去溶剂,再加入300mL甲醇复溶,加入对甲苯磺酸(899mg,10%),在常温下反应12小时,TLC(EA/Hex=1/9)表明原料反应完全。再用饱和碳酸氢钠溶液调节反应液pH至8,分液漏斗分出有机层,减压除去溶剂,柱层析分离纯化,洗脱液比例(EA/Hex=1/12-CH 3OH/DCM=1/9),旋干有机相,抽真空至恒重,得白色固体化合物B-1(11.8g,25.5mmol)产率51%(以乙酰甘露糖计收率)。核磁数据如下所示: Step 2: Dissolve the crude compound A-1 (about 47.3mmol) in 200mL of anhydrous DMF, add PhCH(OMe) 2 (7.9g, 52.03mmol, 1.1eq), p-toluenesulfonic acid (899mg, 4.7mmol, 0.1eq), the reaction temperature was controlled at 50°C, and the reaction was carried out under reduced pressure for 2 hours. TLC (CH 3 OH/DCM=1/9) indicated that the reaction of the raw materials was complete. The reaction was cooled to room temperature, NaH (5.68g, 141.9mmol, 3.0eq) was added under an ice bath and reacted for 20 minutes, then BnBr (20.2g, 118.3mmol, 2.5eq) was added. After 20 minutes, the ice bath was removed and stirred at room temperature for 12 hours. , TLC (EA/Hex=1/4) indicates that the conversion of the raw material is complete. The NaH was quenched with methanol (10 mL) in an ice bath, the reaction solution was diluted by adding ethyl acetate (200 mL), and the reaction solution was washed three times with saturated brine (200 mL), concentrated under reduced pressure to remove the solvent, and then reconstituted by adding 300 mL of methanol. P-toluenesulfonic acid (899mg, 10%) was reacted at room temperature for 12 hours. TLC (EA/Hex=1/9) indicated that the reaction of the raw materials was complete. Then adjust the pH of the reaction solution to 8 with saturated sodium bicarbonate solution, separate the organic layer with a separatory funnel, remove the solvent under reduced pressure, and separate and purify by column chromatography. The eluent ratio (EA/Hex=1/12-CH 3 OH/ DCM=1/9), spin-dry the organic phase, vacuum to constant weight, and obtain a white solid compound B-1 (11.8 g, 25.5 mmol) with a yield of 51% (yield based on acetylmannose). The NMR data is as follows:
1H NMR(600MHz,CDCl 3)δ7.37–7.21(m,12H),7.06(d,J=7.9Hz,2H),5.45(d,J=1.3Hz,1H),4.60(d,J=12.2Hz,1H),4.57–4.46(m,3H),4.17–4.00(m,2H),3.94(dd,J=3.0,1.5Hz,1H),3.85–3.73(m,2H),3.68(dd,J=9.1,3.1Hz,1H),3.35(s,1H),2.70(d,J=3.7Hz,1H),2.28(s,3H). 1 H NMR(600MHz, CDCl 3 )δ7.37–7.21(m,12H), 7.06(d,J=7.9Hz,2H), 5.45(d,J=1.3Hz,1H), 4.60(d,J= 12.2Hz, 1H), 4.57–4.46(m, 3H), 4.17–4.00(m, 2H), 3.94(dd, J=3.0, 1.5Hz, 1H), 3.85–3.73(m, 2H), 3.68(dd ,J=9.1,3.1Hz,1H), 3.35(s,1H), 2.70(d,J=3.7Hz,1H), 2.28(s,3H).
第三步:称取化合物B-1(6.3g,13.6mmol)置于250mL的茄型瓶中,加入水和二氯甲烷(v/v=1/2)混合溶液87mL,呈无色透明,加入 TEMPO(424mg,2.7mmol,0.2eq),溶液变成红褐色,再加入PhI(OAc) 2(10.9g,33.9mmol,2.5eq),在室温下剧烈搅拌3小时,溶液变成棕黄色,TLC(EA/Hex=1/1)表明有原料反应完全。在反应液中加入饱和Na 2S 2O 3水溶液(10mL),用稀盐酸调节pH=3,搅拌10分钟,加入二氯甲烷100mL萃取分液,减压除去溶剂,再加入180mL丙酮复溶,加入BnBr(4.6g,27.2mmol,2eq),K 2CO 3(2.8g,20.4mmol,1.5eq),在氮气保护下,室温搅拌反应3小时,溶液为红褐色,TLC(CH 3OH/DCM=1/9)表明原料完全消失,将反应液用稀盐酸调节pH至中性,用二氯甲烷(100mL)萃取分液,减压浓缩有机相,柱层析纯化(EA/Hex=1/10-1/1),得红褐色油状物化合物I-1(4.3g,7.5mmol),产率55%(以化合物B-1计)。核磁图谱数据如下所示: The third step: Weigh compound B-1 (6.3g, 13.6mmol) into a 250mL eggplant-shaped bottle, add 87mL of a mixed solution of water and dichloromethane (v/v=1/2), which is colorless and transparent. Add TEMPO (424mg, 2.7mmol, 0.2eq), the solution turns reddish brown, then add PhI(OAc) 2 (10.9g, 33.9mmol, 2.5eq), stir vigorously at room temperature for 3 hours, the solution turns brownish yellow, TLC (EA/Hex=1/1) indicates that the reaction of the raw materials is complete. Add a saturated Na 2 S 2 O 3 aqueous solution (10 mL) to the reaction solution, adjust the pH to 3 with dilute hydrochloric acid, stir for 10 minutes, add 100 mL of dichloromethane for extraction, remove the solvent under reduced pressure, and then add 180 mL of acetone for reconstitution. Add BnBr (4.6g, 27.2mmol, 2eq), K 2 CO 3 (2.8g, 20.4mmol, 1.5eq), under nitrogen protection, stir the reaction at room temperature for 3 hours, the solution is reddish brown, TLC (CH 3 OH/DCM =1/9) indicates that the raw materials have completely disappeared. The reaction solution was adjusted to neutral pH with dilute hydrochloric acid, and the solution was extracted and separated with dichloromethane (100mL). The organic phase was concentrated under reduced pressure and purified by column chromatography (EA/Hex=1/ 10-1/1) to obtain compound I-1 (4.3 g, 7.5 mmol) as a reddish-brown oil, with a yield of 55% (calculated as compound B-1). The NMR spectrum data is as follows:
1H NMR(600MHz,CDCl 3)δ7.70–7.28(m,17H),6.97(d,J=7.9Hz,2H),5.23(dd,J=44.0,12.3Hz,2H),5.00(d,J=11.4Hz,1H),4.86(d,J=11.4Hz,1H),4.75(q,J=12.0Hz,2H),4.68(d,J=0.9Hz,1H),4.45(td,J=9.5,2.5Hz,1H),4.10(t,J=6.4Hz,1H),3.76(d,J=9.6Hz,1H),3.58–3.41(m,1H),3.08(d,J=2.5Hz,1H),2.30(s,3H). 1 H NMR(600MHz, CDCl 3 )δ7.70–7.28(m,17H), 6.97(d,J=7.9Hz,2H), 5.23(dd,J=44.0,12.3Hz,2H), 5.00(d, J = 11.4 Hz, 1H), 4.86 (d, J = 11.4 Hz, 1H), 4.75 (q, J = 12.0 Hz, 2H), 4.68 (d, J = 0.9 Hz, 1H), 4.45 (td, J = 9.5,2.5Hz,1H),4.10(t,J=6.4Hz,1H), 3.76(d,J=9.6Hz,1H),3.58–3.41(m,1H),3.08(d,J=2.5Hz, 1H), 2.30(s, 3H).
实施例2:化合物II-1的合成Example 2: Synthesis of compound II-1
第一步:称取化合物I-1(15.0g,26.3mmol)置于1000mL茄型瓶中,加入400mL的无水二氯甲烷,溶液呈红褐色,加入LevOH(7.6g,65.8mmol,2.5eq),DIC(8.3g,10.2mL,65.8mmol,2.5eq),及DMAP(8.1g,65.8mmol,2.5eq),室温下搅拌3小时,溶液变为棕黄色浑浊。TLC(EA/Hex=1/2)表明原料转化完全。加入饱和食盐水(500mL),萃取分液,减压浓缩有机相,得粗产物化合物D-1直接用于下一步。The first step: Weigh compound I-1 (15.0g, 26.3mmol) into a 1000mL eggplant-shaped bottle, add 400mL of anhydrous dichloromethane, the solution is reddish brown, add LevOH (7.6g, 65.8mmol, 2.5eq ), DIC (8.3g, 10.2mL, 65.8mmol, 2.5eq), and DMAP (8.1g, 65.8mmol, 2.5eq), stirred at room temperature for 3 hours, the solution became brownish yellow and turbid. TLC (EA/Hex=1/2) indicates that the conversion of the raw material is complete. Saturated brine (500 mL) was added, the liquids were separated by extraction, and the organic phase was concentrated under reduced pressure to obtain the crude product compound D-1, which was directly used in the next step.
第二步:将粗品化合物D-1溶于320mL丙酮/水(v/v=15/1),呈淡黄色溶液加入NBS(16.8g,4eq),数分钟后变成红褐色,室温搅拌1小时,溶液变淡黄色。TLC(EA/Hex=1/2)表明原料转化完全。用饱和Na 2S 2O 3溶液(10mL)淬灭反应,再加入二氯甲烷(500mL)萃取,饱和食盐水 洗涤有机层一次,减压浓缩除去溶剂,得黄色油状物化合物E-1直接用于下一步反应。 Step 2: Dissolve the crude compound D-1 in 320mL of acetone/water (v/v=15/1), add NBS (16.8g, 4eq) as a pale yellow solution, turn it into reddish brown after a few minutes, stir at room temperature for 1 Hours, the solution turns pale yellow. TLC (EA/Hex=1/2) indicates that the conversion of the raw material is complete. The reaction was quenched with saturated Na 2 S 2 O 3 solution (10 mL), and dichloromethane (500 mL) was added for extraction. The organic layer was washed once with saturated brine, and concentrated under reduced pressure to remove the solvent to obtain a yellow oil compound E-1. Use directly In the next step.
第三步:将上步粗品化合物E-1溶于90mL无水二氯甲烷中,加入CNCCl 3(6.3g,4.3mL,5eq)和DBU(663mg,0.7mL,4.4mmol,0.5eq),溶液呈深褐色,冰浴下搅拌3小时。TLC(EA/Hex=1/2)表明原料转化完全。减压浓缩反应液,柱层析分离纯化,洗脱液比例(EA/Hex=1/6-1/1),得淡黄色油状化合物II-1(13.5g,19.2mmol)收率73%(以化合物I-1计)。核磁数据如下所示: Step 3: Dissolve the crude compound E-1 from the previous step in 90mL of anhydrous dichloromethane, add CNCCl 3 (6.3g, 4.3mL, 5eq) and DBU (663mg, 0.7mL, 4.4mmol, 0.5eq), solution It was dark brown and stirred under ice bath for 3 hours. TLC (EA/Hex=1/2) indicates that the conversion of the raw material is complete. The reaction solution was concentrated under reduced pressure, and separated and purified by column chromatography. The eluent ratio (EA/Hex=1/6-1/1) gave compound II-1 (13.5g, 19.2mmol) as a pale yellow oil with a yield of 73% ( Based on compound I-1). The NMR data is as follows:
1H NMR(400MHz,CDCl 3)δ7.43–7.16(m,15H),6.53(d,J=3.3Hz,1H),5.60(t,J=7.5Hz,1H),5.12(t,J=12.9Hz,1H),5.03(d,J=12.2Hz,1H),4.88(d,J=46.7Hz,2H),4.65(ddd,J=34.3,16.0,6.9Hz,1H),4.51(d,J=7.6Hz,1H),4.49–4.38(m,1H),3.89(dd,J=7.8,2.9Hz,1H),3.85–3.76(m,1H),2.72–2.44(m,3H),2.39(d,J=7.2Hz,1H),2.15(d,J=11.7Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ7.43-7.16 (m, 15H), 6.53 (d, J = 3.3 Hz, 1H), 5.60 (t, J = 7.5 Hz, 1H), 5.12 (t, J = 12.9Hz, 1H), 5.03 (d, J = 12.2 Hz, 1H), 4.88 (d, J = 46.7 Hz, 2H), 4.65 (ddd, J = 34.3, 16.0, 6.9 Hz, 1H), 4.51 (d, J=7.6Hz,1H), 4.49–4.38(m,1H), 3.89(dd,J=7.8,2.9Hz,1H), 3.85–3.76(m,1H), 2.72–2.44(m,3H), 2.39 (d,J=7.2Hz,1H), 2.15(d,J=11.7Hz,3H).
实施例3:化合物III-1的合成Example 3: Synthesis of compound III-1
称取化合物D-1(300mg,0.45mmol)溶于20mL无水DCM,氮气保护下加入TTBP(334.8mg,1.35mmol,3eq),二苯亚砜(109mg,0.54mmol,1.2eq),干燥的4埃分子筛(500mg),溶液在-78℃下搅拌10分钟。加入Tf 2O(141mg,0.5mmol,1.1eq)。溶液搅拌10分钟,加入苄醇(54mg,0.5mmol,1.1eq),在-78℃反应1小时,TLC(EA/Hex=1/2)表明原料转化完全。加饱和碳酸氢钠调节pH至中性,除去分子筛,减压浓缩有机相得粗品化合物F-1,复溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(180mg,1.95mmol,4.33eq),室温下搅拌2小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/4-1/1),得无色油状物化合物III-1(224mg,0.41mmol),产率90%(以化合物D-1计)。核磁数 据如下所示: Weigh compound D-1 (300mg, 0.45mmol) dissolved in 20mL of anhydrous DCM, add TTBP (334.8mg, 1.35mmol, 3eq), diphenyl sulfoxide (109mg, 0.54mmol, 1.2eq), dry 4 angstrom molecular sieves (500 mg), and the solution was stirred at -78°C for 10 minutes. Tf 2 O (141 mg, 0.5 mmol, 1.1 eq) was added. The solution was stirred for 10 minutes, and benzyl alcohol (54 mg, 0.5 mmol, 1.1 eq) was added and reacted at -78°C for 1 hour. TLC (EA/Hex=1/2) indicated that the conversion of the raw material was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure to obtain the crude compound F-1, redissolve it in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (180mg , 1.95mmol, 4.33eq), stirred at room temperature for 2 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The eluent ratio (EA/Hex=1/4-1/1) gave compound III-1 (224 mg, 0.41 mmol) as a colorless oil with a yield of 90% (calculated as compound D-1). The NMR data is as follows:
1H NMR(600MHz,CDCl 3)δ7.49–7.06(m,20H),5.24(q,J=12.3Hz,2H),5.03(d,J=1.6Hz,1H),4.74(d,J=11.9Hz,1H),4.70–4.54(m,3H),4.50(d,J=11.9Hz,1H),4.35(td,J=9.2,2.4Hz,1H),4.20(d,J=9.3Hz,1H),3.80(dd,J=9.2,3.0Hz,1H),3.78–3.71(m,1H),2.82(d,J=2.4Hz,1H). 1 H NMR (600MHz, CDCl 3 ) δ7.49–7.06 (m, 20H), 5.24 (q, J = 12.3 Hz, 2H), 5.03 (d, J = 1.6 Hz, 1H), 4.74 (d, J = 11.9Hz, 1H), 4.70–4.54 (m, 3H), 4.50 (d, J = 11.9 Hz, 1H), 4.35 (td, J = 9.2, 2.4 Hz, 1H), 4.20 (d, J = 9.3 Hz, 1H), 3.80(dd,J=9.2,3.0Hz,1H), 3.78–3.71(m,1H), 2.82(d,J=2.4Hz,1H).
实施例4:化合物IV-1的合成Example 4: Synthesis of compound IV-1
称取化合物II-1(2.0g,2.84mmol)和化合物III-1(1.7g,3.12mmol,1.1eq)溶于80mL的无水DCM中,溶液呈红褐色,加入干燥的4埃分子筛(1.8g),在-40℃下搅拌10min后加入TMSOTf(126mg,0.57mmol,0.2eq),N 2保护下搅拌反应1小时,TLC(EA/Hex=1/2)表明化合物II-1消失。加三乙胺调节pH至中性,除去分子筛,减压浓缩有机相,复溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(1130mg,12.3mmol,4.33eq),室温下搅拌5小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/8-1/1),得淡黄色油状物化合物IV-1(1813mg,1.8mmol)产率64%。核磁数据如下所示: Weigh compound II-1 (2.0g, 2.84mmol) and compound III-1 (1.7g, 3.12mmol, 1.1eq) and dissolve in 80mL of anhydrous DCM. The solution is reddish brown. Add dry 4 angstrom molecular sieve (1.8 g) After stirring at -40°C for 10 min, TMSOTf (126 mg, 0.57 mmol, 0.2 eq) was added, and the reaction was stirred under N 2 protection for 1 hour. TLC (EA/Hex=1/2) indicated that compound II-1 disappeared. Add triethylamine to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure, re-dissolve in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (1130mg, 12.3mmol, 4.33eq) , Stir at room temperature for 5 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The ratio of the eluent (EA/Hex=1/8-1/1) gave compound IV-1 (1813 mg, 1.8 mmol) as a pale yellow oil with a yield of 64%. The NMR data is as follows:
1H NMR(600MHz,CDCl 3)δ7.35–6.92(m,35H),5.19(s,1H),5.08(d,J=12.2Hz,1H),5.00(d,J=12.2Hz,1H),4.94(d,J=12.2Hz,1H),4.80(dd,J=27.2,12.1Hz,2H),4.71(d,J=12.2Hz,1H),4.57(dd,J=12.1,4.8Hz,2H),4.52–4.35(m,8H),4.35–4.28(m,1H),4.18(t,J=9.5Hz,1H),4.03–3.93(m,1H),3.72(t,J=4.2Hz,1H),3.64–3.56(m,2H),3.15(dd,J=9.5,2.8Hz,1H),2.94(s,1H). 1 H NMR(600MHz,CDCl 3 )δ7.35-6.92(m,35H),5.19(s,1H),5.08(d,J=12.2Hz,1H),5.00(d,J=12.2Hz,1H) , 4.94 (d, J = 12.2Hz, 1H), 4.80 (dd, J = 27.2, 12.1Hz, 2H), 4.71 (d, J = 12.2Hz, 1H), 4.57 (dd, J = 12.1, 4.8 Hz, 2H), 4.52–4.35(m,8H), 4.35–4.28(m,1H), 4.18(t,J=9.5Hz,1H), 4.03-3.93(m,1H), 3.72(t,J=4.2Hz ,1H), 3.64–3.56(m,2H), 3.15(dd,J=9.5,2.8Hz,1H), 2.94(s,1H).
实施例5:β-D-(1,4)-甘露糖醛酸二糖(化合物IX-1)的合成Example 5: Synthesis of β-D-(1,4)-mannuronic acid disaccharide (Compound IX-1)
将化合物IV-1(500mg,0.5mmol)溶于22mL的THF/H 2O/t-BuOH(v/v/v=1/1/0.2)中,加入钯炭(钯含量10%)(50mg),在氢气下25℃搅拌反应48小时,TLC(EA/Hex=1/2)表明原料消失,滤除钯炭,用水(50mL*3)洗涤三次钯炭层,合并水相,用EA(100mL)萃取一次,减压浓缩水至10mL,冷冻干燥,得白色固体化合物IX-1(160mg,0.4mmol),收率86%。核磁数据如下所示: Compound IV-1 (500mg, 0.5mmol) was dissolved in 22mL of THF/H 2 O/t-BuOH (v/v/v=1/1/0.2), and palladium on carbon (palladium content 10%) (50mg ), the reaction was stirred at 25°C under hydrogen for 48 hours. TLC (EA/Hex=1/2) indicated that the raw materials disappeared. The palladium-carbon layer was filtered off, and the palladium-carbon layer was washed three times with water (50mL*3). The aqueous phases were combined, and EA( 100 mL) was extracted once, the water was concentrated to 10 mL under reduced pressure, and then freeze-dried to obtain a white solid compound IX-1 (160 mg, 0.4 mmol) with a yield of 86%. The NMR data is as follows:
1H NMR(600MHz,D2O)δ5.23–5.12(m,1H),4.75(d,J=9.4Hz,1H),4.67–4.57(m,1H),4.40(t,J=6.8Hz,1H),4.08(dt,J=45.1,20.4Hz,1H),4.02–3.85(m,2H),3.85–3.67(m,2H),3.67–3.48(m,1H). 1 H NMR(600MHz,D2O)δ5.23-5.12(m,1H), 4.75(d,J=9.4Hz,1H), 4.67-4.57(m,1H), 4.40(t,J=6.8Hz,1H ), 4.08(dt, J=45.1,20.4Hz,1H), 4.02–3.85(m,2H), 3.85–3.67(m,2H), 3.67–3.48(m,1H).
13C NMR(151MHz,D 2O)δ172.85,172.73,101.35,101.06,99.82,95.47,94.08,93.28,92.97,79.52,77.87,76.14,75.36,75.22,72.32,72.27,71.82,71.16,70.11,69.96,69.84,69.80,69.75,69.64,69.59,69.53,69.43,69.21,69.04,67.91,67.79,67.75,67.66. 13 C NMR (151MHz, D 2 O) δ 172.85, 172.73, 101.35, 101.06, 99.82, 95.47, 94.08, 93.28, 92.97, 79.52, 77.87, 76.14, 75.36, 75.22, 72.32, 72.27, 71.82, 71.16, 70.11, 69.96, 69.84, 69.80, 69.75, 69.64, 69.59, 69.53, 69.43, 69.21, 69.04, 67.91, 67.79, 67.75, 67.66.
实施例6:化合物VI-1的合成Example 6: Synthesis of compound VI-1
称取化合物II-1(2.0g,2.84mmol)和化合物I-1(1.78g,3.13mmol,1.1eq)溶于80mL的无水DCM中,呈红褐色,加入干燥的4埃分子筛(2.0g),在-40℃下搅拌10min后加入TMSOTf(126mg,0.57mmol,0.2eq),N 2保护下搅拌1小时,TLC(EA/Hex=1/2)表明化合物II-1反应完全。加入饱和碳酸氢钠调节pH至中性,过滤除去分子筛,萃取干燥浓缩,柱层析分离纯化,洗脱液比例(EA/Hex=1/8-1/1),得淡黄色固体化合物VI-1(2.7g,2.42mmol),产率86%。核磁数据如下所示: Weigh compound II-1 (2.0g, 2.84mmol) and compound I-1 (1.78g, 3.13mmol, 1.1eq) in 80mL of anhydrous DCM, reddish brown, add dry 4 angstrom molecular sieve (2.0g ), after stirring at -40°C for 10 min, TMSOTf (126 mg, 0.57 mmol, 0.2 eq) was added, and stirring under N 2 protection for 1 hour, TLC (EA/Hex = 1/2) indicated that the reaction of compound II-1 was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, filter to remove molecular sieves, extract, dry and concentrate, separate and purify by column chromatography, eluent ratio (EA/Hex=1/8-1/1), to obtain light yellow solid compound VI- 1 (2.7g, 2.42mmol), yield 86%. The NMR data is as follows:
1H NMR(600MHz,CDCl 3)δ7.39–7.15(m,34H),6.90(d,J=8.0Hz,2H),5.68(d,J=6.8Hz,1H),5.56–5.46(m,1H),5.13–5.02(m,2H),4.92(dd,J=36.4,12.2Hz,2H),4.75–4.53(m,3H),4.53–4.38(m,7H),4.38–4.26(m,1H),4.16(s,1H),3.83(dt,J=9.6,3.2Hz,2H),3.73(dd,J=8.1,2.7Hz,1H),3.40(dd,J=9.6,2.8Hz,1H),2.57(dt,J=19.8,7.8Hz,1H),2.52–2.37(m,2H),2.36–2.25(m,1H),2.22(s,3H),2.15–2.05(m,3H) 1 H NMR(600MHz, CDCl 3 )δ7.39–7.15(m,34H), 6.90(d,J=8.0Hz,2H), 5.68(d,J=6.8Hz,1H), 5.56–5.46(m, 1H), 5.13–5.02(m,2H), 4.92(dd,J=36.4, 12.2Hz, 2H), 4.75–4.53(m,3H), 4.53–4.38(m,7H), 4.38–4.26(m, 1H), 4.16 (s, 1H), 3.83 (dt, J = 9.6, 3.2 Hz, 2H), 3.73 (dd, J = 8.1, 2.7 Hz, 1H), 3.40 (dd, J = 9.6, 2.8 Hz, 1H ), 2.57(dt,J=19.8,7.8Hz,1H),2.52–2.37(m,2H),2.36–2.25(m,1H),2.22(s,3H),2.15–2.05(m,3H)
实施例7:β-D-(1,4)-甘露糖醛酸四糖(化合物IX-2)的合成Example 7: Synthesis of β-D-(1,4)-mannuronic acid tetraose (compound IX-2)
第一步:称取VI-1(500mg,0.45mmol)溶于20mL无水DCM,氮气保护下加入TTBP(334.8mg,1.35mmol,3eq),二苯亚砜(109mg,0.54mmol,1.2eq),干燥的4埃分子筛500mg),溶液在-78℃下搅拌10分钟。加入Tf 2O(141mg,0.5mmol,1.1eq)。溶液搅拌10分钟,加入化合物IV-1(500mg,0.5mmol,1.1eq),反应在-78℃反应1小时,TLC(EA/Hex=1/2)表明原料转化完全。加饱和碳酸氢钠调节pH至中性,除去分子筛,减压浓缩有机相,复溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(180mg,1.95mmol,4.33eq),室温下搅拌2小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/4-1/1),得淡黄色固体化合物VIII-1(766mg,0.405mmol),产率90%(以化合物VI-1计)。 The first step: Weigh VI-1 (500mg, 0.45mmol) and dissolve in 20mL of anhydrous DCM, add TTBP (334.8mg, 1.35mmol, 3eq), diphenyl sulfoxide (109mg, 0.54mmol, 1.2eq) under nitrogen protection , Dry 4 angstrom molecular sieve 500mg), the solution was stirred at -78 ℃ for 10 minutes. Tf 2 O (141 mg, 0.5 mmol, 1.1 eq) was added. The solution was stirred for 10 minutes, compound IV-1 (500 mg, 0.5 mmol, 1.1 eq) was added, and the reaction was carried out at -78° C. for 1 hour. TLC (EA/Hex = 1/2) indicated that the conversion of the raw material was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure, redissolve it in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (180mg, 1.95mmol, 4.33eq ), stirring at room temperature for 2 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, then add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The ratio of the eluent (EA/Hex=1/4-1/1) gave compound VIII-1 (766 mg, 0.405 mmol) as a pale yellow solid, with a yield of 90% (calculated as compound VI-1).
第二步:将化合物VIII-1(766mg,0.405mmol)溶于22mL的THF/H 2O/t-BuOH(v/v/v=1/1/0.2)中,加入钯炭(钯含量10%)(300mg),在氢气下25℃搅拌反应48小时,TLC(EA/Hex=1/2)表明原料消失,滤除钯炭,用水(50mL*3)洗涤三次钯炭层,合并水相,用EA(100mL)萃取一次,减压浓缩水至10mL,冷冻干燥,得白色固体化合物IX-2(263mg,0.365mmol),收率90%。 Step 2: Dissolve compound VIII-1 (766mg, 0.405mmol) in 22mL of THF/H 2 O/t-BuOH (v/v/v=1/1/0.2), add palladium on carbon (palladium content 10 %) (300mg), the reaction was stirred at 25°C under hydrogen for 48 hours. TLC (EA/Hex=1/2) indicated that the raw material disappeared. The palladium-carbon layer was filtered off, and the palladium-carbon layer was washed three times with water (50mL*3), and the aqueous phases were combined. , Extracted once with EA (100 mL), concentrated water to 10 mL under reduced pressure, and freeze-dried to obtain white solid compound IX-2 (263 mg, 0.365 mmol) with a yield of 90%.
1H NMR(600MHz,D 2O)δ5.22(d,J=4.4Hz,1H),4.98–4.80(m,2H),4.82–4.76(m,2H),4.46(d,J=6.6Hz,1H),4.17(t,J=6.9Hz,1H),4.13–3.87(m,8H),3.87–3.65(m,3H),3.65–3.48(m,2H). 1 H NMR(600MHz,D 2 O)δ5.22(d,J=4.4Hz,1H), 4.98–4.80(m,2H), 4.82–4.76(m,2H), 4.46(d,J=6.6Hz ,1H), 4.17(t,J=6.9Hz,1H), 4.13–3.87(m,8H), 3.87–3.65(m,3H), 3.65–3.48(m,2H).
13C NMR(150MHz,D 2O)δ172.68,172.11,171.66,100.40,100.37,99.86,95.47,93.99,92.93,77.94,77.84,77.66,76.54,75.23,74.38,73.03,72.93,72.31,71.81,71.16,70.97,69.97,69.60,69.53,69.46,69.19,69.04,67.63. 13 C NMR (150MHz, D 2 O) δ172.68,172.11,171.66,100.40,100.37,99.86,95.47,93.99,92.93,77.94,77.84,77.66,76.54,75.23,74.38,73.03,72.93,72.31,71.81,71.16, 70.97, 69.97, 69.60, 69.53, 69.46, 69.19, 69.04, 67.63.
实施例8:β-D-(1,4)-甘露糖醛酸三糖(化合物IX-3)的合成Example 8: Synthesis of β-D-(1,4)-mannuronic acid triose (compound IX-3)
第一步:称取化合物II-1(2.0g,2.84mmol)和化合物IV-1(3.12g,3.13mmol,1.1eq)溶于100mL的无水DCM中,溶液呈红褐色,加入干燥的4埃分子筛(1.8g),在-40℃下搅拌10min后加入TMSOTf(126mg,0.57mmol,0.2eq),N 2保护下搅拌反应1小时。TLC(EA/Hex=1/2)表明化合物II-1消失。加三乙胺调节pH至中性,除去分子筛,减压浓缩有机相,复溶于50mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(1130mg,12.3mmol,4.33eq),室温下搅拌5小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/8-1/1),,得淡黄色油状物化合物V-1(2547mg,1.76mmol)产率62%。核磁数据如下所示: The first step: Weigh compound II-1 (2.0g, 2.84mmol) and compound IV-1 (3.12g, 3.13mmol, 1.1eq) and dissolve in 100mL of anhydrous DCM, the solution is reddish brown, add dry 4 angstrom molecular sieves (1.8g), stirred at -40 ℃ was added TMSOTf (126mg, 0.57mmol, 0.2eq) after 10min, the reaction was stirred under N 2 for 1 hour. TLC (EA/Hex=1/2) indicated that compound II-1 disappeared. Add triethylamine to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure, re-dissolve in 50mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (1130mg, 12.3mmol, 4.33eq) , Stir at room temperature for 5 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The eluent ratio (EA/Hex=1/8-1/1) gave compound V-1 (2547 mg, 1.76 mmol) as a pale yellow oil with a yield of 62%. The NMR data is as follows:
1H NMR(600MHz,CDCl3)δ7.26(ddd,J=48.8,27.9,19.6Hz,50H),5.25(s,1H),5.14–4.97(m,4H),4.88(dd,J=27.9,12.0Hz,3H),4.73(t,J=11.9Hz,2H),4.62(ddd,J=33.3,22.0,11.5Hz,6H),4.54–4.39(m,8H),4.39–4.27(m,2H),4.17(t,J=8.7Hz,1H),4.04(s,1H),3.79(d,J=8.3Hz,1H),3.70(d,J=14.7Hz,3H),3.48(d,J=9.3Hz,1H),3.45–3.34(m,1H),3.11(d,J=8.3Hz,1H),2.82(s,1H). 1 H NMR (600MHz, CDCl3) δ 7.26 (ddd, J = 48.8, 27.9, 19.6 Hz, 50H), 5.25 (s, 1H), 5.14-4.97 (m, 4H), 4.88 (dd, J = 27.9, 12.0Hz, 3H), 4.73 (t, J = 11.9 Hz, 2H), 4.62 (ddd, J = 33.3, 22.0, 11.5 Hz, 6H), 4.54–4.39 (m, 8H), 4.39–4.27 (m, 2H) ), 4.17 (t, J = 8.7 Hz, 1H), 4.04 (s, 1H), 3.79 (d, J = 8.3 Hz, 1H), 3.70 (d, J = 14.7 Hz, 3H), 3.48 (d, J =9.3Hz,1H), 3.45–3.34(m,1H), 3.11(d,J=8.3Hz,1H), 2.82(s,1H).
第二步:将化合物V-1(500mg,0.34mmol)溶于20mL的THF/H 2O/t-BuOH(v/v/v=1/1/0.2)中,加入钯炭(钯含量10%)(50mg),在氢气下25℃搅拌反应48小时,TLC(EA/Hex=1/2)表明原料消失,滤除钯炭,用水(50mL*3)洗涤三次钯炭层,合并水相,用EA(100mL)萃取一次,减压浓缩水至10mL,冷冻干燥,得白色固体化合物IX-3(167mg,0.31mmol),收率90%。核磁数据如下所示: Step 2: Dissolve compound V-1 (500mg, 0.34mmol) in 20mL of THF/H 2 O/t-BuOH (v/v/v=1/1/0.2), add palladium on carbon (palladium content 10 %) (50mg), the reaction was stirred at 25°C under hydrogen for 48 hours. TLC (EA/Hex=1/2) indicated that the raw materials disappeared. The palladium-carbon layer was filtered off, and the palladium-carbon layer was washed three times with water (50mL*3), and the aqueous phases were combined. , Extracted once with EA (100 mL), concentrated water to 10 mL under reduced pressure, and freeze-dried to obtain white solid compound IX-3 (167 mg, 0.31 mmol) with a yield of 90%. The NMR data is as follows:
1H NMR(600MHz,D 2O)δ5.17(d,J=4.3Hz,1H),4.77(s,1H),4.41(d,J=6.6Hz,1H),4.11(d,J=6.7Hz,1H),4.05–3.94(m,3H),3.94–3.89(m,2H),3.88(d,J=9.9Hz,1H),3.82–3.77(m,1H),3.77–3.65(m,3H),3.58(dd,J=9.5,3.0Hz,1H). 1 H NMR (600MHz, D 2 O) δ 5.17 (d, J = 4.3 Hz, 1H), 4.77 (s, 1H), 4.41 (d, J = 6.6 Hz, 1H), 4.11 (d, J = 6.7 Hz,1H),4.05–3.94(m,3H),3.94–3.89(m,2H), 3.88(d,J=9.9Hz,1H), 3.82–3.77(m,1H), 3.77–3.65(m, 3H), 3.58 (dd, J=9.5, 3.0Hz, 1H).
13C NMR(151MHz,D2O)δ185.70,172.66,172.09,171.67,100.34,99.85,93.97,92.93,77.93,77.84,77.73,77.64,74.36,73.03,72.30,71.79,71.12,70.95,70.56,70.08,69.98,69.55,69.48,69.18,69.02,67.72,67.61. 13 C NMR (151MHz, D2O) δ185.70,172.66,172.09,171.67,100.34,99.85,93.97,92.93,77.93,77.84,77.73,77.64,74.36,73.03,72.30,71.79,71.12,70.95,70.56,70.08,69.98, 69.55, 69.48, 69.18, 69.02, 67.72, 67.61.
实施例9:β-D-(1,4)-甘露糖醛酸五糖(化合物IX-4)的合成Example 9: Synthesis of β-D-(1,4)-mannuronic acid pentasaccharide (Compound IX-4)
第一步:称取VI-1(500mg,0.45mmol)溶于20mL无水DCM,氮气保护下加入TTBP(334.8mg,1.35mmol,3eq),二苯亚砜(109mg,0.54mmol,1.2eq),干燥的4埃分子筛500mg),溶液在-78℃下搅拌10分钟,加入Tf 2O(141mg,0.5mmol,1.1eq),溶液搅拌10分钟,加入化合物V-1(723mg,0.5mmol,1.1eq),反应在-78℃反应1小时,TLC(EA/Hex=1/2)表明原料转化完全。加饱和碳酸氢钠调节pH至中性,除去分子筛,减压浓缩有机相,复溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(180mg,1.95mmol,4.33eq),室温下搅拌2小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/4-1/1),得淡黄色固体化合物VIII-2(935mg,0.40mmol),产率88%(以化合物VI-1计)。 The first step: Weigh VI-1 (500mg, 0.45mmol) and dissolve in 20mL of anhydrous DCM, add TTBP (334.8mg, 1.35mmol, 3eq), diphenyl sulfoxide (109mg, 0.54mmol, 1.2eq) under nitrogen protection , Dry 4 angstrom molecular sieve 500mg), the solution was stirred at -78 ℃ for 10 minutes, Tf 2 O (141mg, 0.5mmol, 1.1eq) was added, the solution was stirred for 10 minutes, compound V-1 (723mg, 0.5mmol, 1.1 eq), the reaction was carried out at -78°C for 1 hour, and TLC (EA/Hex=1/2) indicated that the conversion of the raw materials was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure, redissolve it in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (180mg, 1.95mmol, 4.33eq ), stirring at room temperature for 2 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The eluent ratio (EA/Hex = 1/4-1/1) yielded a pale yellow solid compound VIII-2 (935 mg, 0.40 mmol), with a yield of 88% (calculated as compound VI-1).
第二步:将化合物VIII-2(935mg,0.40mmol)溶于22mL的THF/H 2O/t-BuOH(v/v/v=1/1/0.2)中,加入钯炭(钯含量10%)(300mg),在氢气下25℃搅拌反应48小时,TLC(EA/Hex=1/2)表明原料消失,滤除钯炭,用水(50mL*3)洗涤三次钯炭层,合并水相,用EA(100mL)萃取一次,减压浓缩水至10mL,冷冻干燥,得白色固体化合物IX-4(323mg,0.36mmol),收率90%。核磁数据如下所示: Step 2: Dissolve compound VIII-2 (935mg, 0.40mmol) in 22mL of THF/H 2 O/t-BuOH (v/v/v=1/1/0.2), add palladium on carbon (palladium content 10 %) (300mg), the reaction was stirred at 25°C under hydrogen for 48 hours. TLC (EA/Hex=1/2) indicated that the raw material disappeared. The palladium-carbon layer was filtered off, and the palladium-carbon layer was washed three times with water (50mL*3), and the aqueous phases were combined. , Extracted once with EA (100 mL), concentrated water to 10 mL under reduced pressure, and freeze-dried to obtain white solid compound IX-4 (323 mg, 0.36 mmol) with a yield of 90%. The NMR data is as follows:
1H NMR(600MHz,D 2O)δ5.17(s,1H),4.86(s,1H),4.63–4.51(m,3H),4.29(d,J=5.8Hz,1H),4.05(s,1H),3.97(s,3H),3.91(t,J=10.4Hz,2H),3.84(d,J=9.3Hz,6H),3.76(dd,J=14.9,7.5Hz,2H),3.72(d,J=18.2Hz,3H),3.58(d,J=7.0Hz,1H),3.53(s,1H). 1 H NMR (600MHz, D 2 O) δ 5.17 (s, 1H), 4.86 (s, 1H), 4.63-4.51 (m, 3H), 4.29 (d, J = 5.8 Hz, 1H), 4.05 (s ,1H),3.97(s,3H),3.91(t,J=10.4Hz,2H),3.84(d,J=9.3Hz,6H),3.76(dd,J=14.9,7.5Hz,2H),3.72 (d,J=18.2Hz,3H),3.58(d,J=7.0Hz,1H),3.53(s,1H).
13C NMR(151MHz,D 2O)δ174.35,174.12,173.65,173.37,172.69,100.23,100.15,99.78,97.86,93.81,93.18,78.07,78.00,77.86,77.79,74.50, 72.39,71.24,70.38,70.15,69.80,69.71,69.51,69.01,67.99,67.45,61.48. 13C NMR (151MHz, D 2 O) δ 174.35, 174.12, 173.65, 173.37, 172.69, 100.23, 100.15, 99.78, 97.86, 93.81, 93.18, 78.07, 78.00, 77.86, 77.79, 74.50, 72.39, 71.24, 70.38, 70.15, 69.80 ,69.71,69.51,69.01,67.99,67.45,61.48.
实施例10:β-D-(1,4)-甘露糖醛酸七糖(化合物IX-5)的合成Example 10: Synthesis of β-D-(1,4)-mannuronic acid heptaose (compound IX-5)
第一步:称取化合物VI-1(500mg,0.45mmol)溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(180mg,1.95mmol,4.33eq),室温下搅拌2小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,加入干燥的4埃分子筛(2.0g),复溶于20mL无水DCM中,再加入化合物II-1(317m g,0.45mmol),溶液呈红褐色,N 2保护下,温度控制在-40℃以下,搅拌10min后加入TMSOTf(20mg,0.09mmol,0.2eq),搅拌1小时。TLC(EA/Hex=1/2)表明化合物II-1反应完全。加入饱和碳酸氢钠调节pH至中性,过滤除去分子筛,萃取干燥浓缩,拌硅胶过柱分离,洗脱液比例(EA/Hex=1/8-1/1),得淡黄色固体化合物VII-1(560m g,0.36mmol),产率80%(以化合物VI-1计)。 Step 1: Weigh compound VI-1 (500mg, 0.45mmol) and dissolve it in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (180mg, 1.95mmol, 4.33eq), and stir at room temperature 2 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and add dry 4 angstroms Molecular sieve (2.0g), re-dissolved in 20mL anhydrous DCM, and then add compound II-1 (317mg, 0.45mmol), the solution is reddish brown, under N 2 protection, the temperature is controlled below -40 ℃, after stirring for 10 min Add TMSOTf (20mg, 0.09mmol, 0.2eq) and stir for 1 hour. TLC (EA/Hex=1/2) indicated that the reaction of compound II-1 was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, filter to remove molecular sieves, extract, dry and concentrate, mix with silica gel and pass through a column for separation. The ratio of eluent is (EA/Hex=1/8-1/1) to obtain a pale yellow solid compound VII- 1 (560mg, 0.36mmol), yield 80% (based on compound VI-1).
第二步:称取VII-1(500mg,0.32mmol)溶于20mL无水DCM,氮气保护下加入TTBP(238mg,0.96mmol,3eq),二苯亚砜(78mg,0.38mmol,1.2eq),干燥的4埃分子筛(500mg),溶液在-78℃下搅拌10分钟,加入Tf 2O(100mg,0.35mmol,1.1eq),溶液搅拌10分钟,加入化合物VIII-1(663mg,0.35mmol,1.1eq),反应在-78℃反应1小时,TLC(EA/Hex=1/2)表明原料转化完全。加饱和碳酸氢钠调节pH至中性,除去分子筛,减压浓缩有机相,复溶于20mL的DCM/吡啶(v/v=4/1)中,加入乙酸肼(128mg,1.39mmol,4.33eq),室温下搅拌2小时。TLC(EA/Hex=1/2)表明原料消失。加入丙酮淬灭反应,用二氯甲烷稀释,再加稀盐酸调节pH至中性,再用饱和食盐水洗涤一次,有机相用无水硫酸钠干燥后过滤,浓缩有机相,柱层析纯化,洗脱液比例(EA/Hex=1/4-1/1),得淡黄色固体化合物VIII-3(880mg,0.27mmol),产率85%(以化合物VII-1计)。 Step 2: Weigh VII-1 (500mg, 0.32mmol) and dissolve in 20mL of anhydrous DCM, add TTBP (238mg, 0.96mmol, 3eq), diphenyl sulfoxide (78mg, 0.38mmol, 1.2eq) under nitrogen protection, Dry 4 angstrom molecular sieve (500mg), the solution was stirred at -78℃ for 10 minutes, Tf 2 O (100mg, 0.35mmol, 1.1eq) was added, the solution was stirred for 10 minutes, and compound VIII-1 (663mg, 0.35mmol, 1.1 eq), the reaction was carried out at -78°C for 1 hour, and TLC (EA/Hex=1/2) indicated that the conversion of the raw materials was complete. Add saturated sodium bicarbonate to adjust the pH to neutral, remove the molecular sieve, concentrate the organic phase under reduced pressure, redissolve it in 20mL of DCM/pyridine (v/v=4/1), add hydrazine acetate (128mg, 1.39mmol, 4.33eq ), stirring at room temperature for 2 hours. TLC (EA/Hex=1/2) indicates the disappearance of the raw material. Add acetone to quench the reaction, dilute with dichloromethane, add dilute hydrochloric acid to adjust the pH to neutral, then wash with saturated brine once, dry the organic phase with anhydrous sodium sulfate and filter, concentrate the organic phase, and purify by column chromatography. The ratio of the eluent (EA/Hex=1/4-1/1) gave compound VIII-3 (880 mg, 0.27 mmol) as a pale yellow solid, with a yield of 85% (calculated as compound VII-1).
第三步:将化合物VIII-3(880mg,0.27mmol)溶于22mL的THF/H 2O/t-BuOH(v/v/v=1/1/0.2)中,加入钯炭(钯含量10%)(300mg), 在氢气下25℃搅拌反应48小时,TLC(EA/Hex=1/2)表明原料消失,滤除钯炭,用水(50mL*3)洗涤三次钯炭层,合并水相,用EA(100mL)萃取一次,减压浓缩水至10mL,冷冻干燥,得白色固体化合物IX-5(300mg,0.24mmol),收率89%。核磁数据如下所示: The third step: Dissolve compound VIII-3 (880mg, 0.27mmol) in 22mL of THF/H 2 O/t-BuOH (v/v/v=1/1/0.2), add palladium on carbon (palladium content 10 %) (300mg), the reaction was stirred at 25°C under hydrogen for 48 hours. TLC (EA/Hex=1/2) indicated that the raw material disappeared. The palladium-carbon layer was filtered off, the palladium-carbon layer was washed three times with water (50mL*3), and the aqueous phases were combined. , Extracted once with EA (100 mL), concentrated water to 10 mL under reduced pressure, and freeze-dried to obtain white solid compound IX-5 (300 mg, 0.24 mmol) with a yield of 89%. The NMR data is as follows:
1H NMR(600MHz,D 2O)δ5.96(d,J=3.9Hz,1H),5.15(s,1H),4.84(s,2H),4.65(d,J=3.9Hz,3H),4.60(s,3H),4.16(s,1H),4.10–4.01(m,1H),3.96(s,3H),3.91(s,2H),3.84(d,J=16.4Hz,5H),3.70(s,6H),3.66(d,J=6.7Hz,4H),3.56(dd,J=12.2,6.7Hz,3H). 1 H NMR (600MHz, D 2 O) δ 5.96 (d, J = 3.9 Hz, 1H), 5.15 (s, 1H), 4.84 (s, 2H), 4.65 (d, J = 3.9 Hz, 3H), 4.60(s,3H), 4.16(s,1H), 4.10–4.01(m,1H), 3.96(s,3H), 3.91(s,2H), 3.84(d,J=16.4Hz,5H), 3.70 (s, 6H), 3.66 (d, J = 6.7 Hz, 4H), 3.56 (dd, J = 12.2, 6.7 Hz, 3H).
13C NMR(151MHz,D 2O)δ174.37,174.05,174.02,174.01,173.94,173.84,173.60,100.23,100.15,99.78,97.86,93.81,93.19,78.08,78.00,77.87,77.79,74.64,72.39,71.25,70.38,70.16,69.80,69.71,69.51,69.01,68.00,67.45,61.49. 13 C NMR (151MHz, D 2 O) δ174.37,174.05,174.02,174.01,173.94,173.84,173.60,100.23,100.15,99.78,97.86,93.81,93.19,78.08,78.00,77.87,77.79,74.64,72.39,71.25, 70.38, 70.16, 69.80, 69.71, 69.51, 69.01, 68.00, 67.45, 61.49.

Claims (21)

  1. 一种制备如式VIII或式IX所示的β-D-(1,4)-甘露糖醛酸寡糖的方法,A method for preparing β-D-(1,4)-mannuronic acid oligosaccharides represented by formula VIII or formula IX,
    Figure PCTCN2021094459-appb-100001
    Figure PCTCN2021094459-appb-100001
    包括:include:
    将化合物V和化合物VII进行偶联反应并选择性脱除保护基R 3生成化合物VIII; Compound V and compound VII are subjected to a coupling reaction and the protective group R 3 is selectively removed to generate compound VIII;
    Figure PCTCN2021094459-appb-100002
    Figure PCTCN2021094459-appb-100002
    以及任选地,将化合物VIII一次性脱除保护基R 2生成如式IX所示的β-D-(1,4)-甘露糖醛酸寡糖; And optionally, removing the protecting group R 2 of compound VIII at one time to generate β-D-(1,4)-mannuronic acid oligosaccharide as shown in formula IX;
    其中,m选自2-18的整数;n和n’各自独立地选自0-8的整数;R 1选自C 1-8烷基、任选地被C 1-8烷基取代的C 6-14芳基;R 2为通过钯炭催化的氢化反应或钯炭催化的氧化反应可以脱除的羟基保护基;R 3为通过钯炭催化的氢化反应或钯炭催化的氧化反应不可以脱除的羟基保护基。 Wherein, m is selected from an integer of 2-18; n and n'are each independently selected from an integer of 0-8; R 1 is selected from C 1-8 alkyl, optionally substituted by C 1-8 alkyl 6-14 aryl group; R 2 is a hydroxyl protecting group that can be removed by hydrogenation reaction catalyzed by palladium-carbon or oxidation reaction catalyzed by palladium-carbon ; R 3 is hydrogenation reaction catalyzed by palladium-carbon or oxidation reaction catalyzed by palladium-carbon Removed hydroxyl protecting group.
  2. 如权利要求1所述的方法,其中所述偶联反应在大位阻有机碱、二苯基亚砜和磺酸酐催化剂存在下进行;再依次脱除4位的羟基保护基R 3和其它位置的羟基保护基R 2,得到如IX所示的β-D-(1,4)-甘露糖醛酸寡糖化合物。 The method according to claim 1, wherein the coupling reaction is carried out in the presence of a large hindered organic base, diphenyl sulfoxide and a sulfonic anhydride catalyst; and then the hydroxyl protecting group R 3 at position 4 and other positions are sequentially removed The hydroxyl protecting group R 2 , to obtain the β-D-(1,4)-mannuronic acid oligosaccharide compound shown in IX.
  3. 如权利要求2所述的方法,其中所述磺酸酐催化剂选自甲磺酸酐、三氟甲磺酸酐或对甲苯磺酸酐。The method of claim 2, wherein the sulfonic anhydride catalyst is selected from methanesulfonic anhydride, trifluoromethanesulfonic anhydride, or p-toluenesulfonic anhydride.
  4. 如权利要求1所述的方法,其还包括:The method of claim 1, further comprising:
    将化合物II和化合物III进行偶联反应生成1,4-糖苷键,然后选择性脱除4位羟基保护基R 3,得到化合物IV; The coupling reaction of compound II and compound III to generate 1,4-glycosidic bonds, and then selective removal of the protective group R 3 of the 4-hydroxyl group to obtain compound IV;
    Figure PCTCN2021094459-appb-100003
    Figure PCTCN2021094459-appb-100003
    之后,将化合物IV与化合物II进行偶联反应生成1,4-糖苷键,然后选择性脱除4位羟基保护基R 3;任选地再将得到的化合物重复进行上述偶联反应和脱保护基R 3的步骤,直至得到化合物V; After that, the compound IV and the compound II are subjected to a coupling reaction to generate 1,4-glycosidic bonds, and then the 4-position hydroxyl protecting group R 3 is selectively removed; optionally, the obtained compound is repeatedly subjected to the above coupling reaction and deprotection Group R 3 until the compound V is obtained;
    Figure PCTCN2021094459-appb-100004
    Figure PCTCN2021094459-appb-100004
    其中,n、R 2和R 3如权利要求1中所定义;R 4选自H、C 1-8烷基、C 6-14芳基;X选自氟、氯、溴、碘。 Wherein, n, R 2 and R 3 are as defined in claim 1; R 4 is selected from H, C 1-8 alkyl, C 6-14 aryl; X is selected from fluorine, chlorine, bromine, and iodine.
  5. 如权利要求4所述的方法,其中所述偶联反应在磺酸催化剂存在下进行;所述磺酸催化剂选自:甲磺酸、三氟甲磺酸、对甲苯磺酸或三 氟甲磺酸三甲基硅酯。The method according to claim 4, wherein the coupling reaction is carried out in the presence of a sulfonic acid catalyst; the sulfonic acid catalyst is selected from the group consisting of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid or trifluoromethanesulfonic acid Trimethylsilyl acid.
  6. 如权利要求1所述的方法,其还包括:The method of claim 1, further comprising:
    将化合物I和化合物II进行偶联反应生成1,4-糖苷键,然后选择性地脱除4位羟基保护基R 3,得到化合物VI; The coupling reaction of compound I and compound II to generate 1,4-glycosidic bonds, and then selective removal of the protective group R 3 of the 4-hydroxyl group to obtain compound VI;
    Figure PCTCN2021094459-appb-100005
    Figure PCTCN2021094459-appb-100005
    将化合物VI与化合物II进行偶联反应生成1,4-糖苷键,然后选择性地脱除4位羟基保护基R 3;任选地再将得到的化合物继续重复进行上述偶联反应和脱保护基R 3的步骤,直至得到化合物VII; The compound VI and compound II are subjected to a coupling reaction to generate 1,4-glycosidic bonds, and then the 4-position hydroxyl protecting group R 3 is selectively removed; optionally, the obtained compound is continued to repeat the above coupling reaction and deprotection Group R 3 until the compound VII is obtained;
    Figure PCTCN2021094459-appb-100006
    Figure PCTCN2021094459-appb-100006
    其中,n’、R 1、R 2和R 3如权利要求1中所定义;R 4选自H、C 1-8烷基、C 6-14芳基;X选自氟、氯、溴、碘。 Wherein, n', R 1 , R 2 and R 3 are as defined in claim 1; R 4 is selected from H, C 1-8 alkyl, C 6-14 aryl; X is selected from fluorine, chlorine, bromine, iodine.
  7. 如权利要求6所述的方法,其中所述偶联反应在磺酸催化剂存在下进行;所述磺酸催化剂选自:甲磺酸、三氟甲磺酸、对甲苯磺酸或三氟甲磺酸三甲基硅酯。The method of claim 6, wherein the coupling reaction is carried out in the presence of a sulfonic acid catalyst; the sulfonic acid catalyst is selected from the group consisting of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid or trifluoromethanesulfonic acid Trimethylsilyl acid.
  8. 如权利要求4-7中任一项所述的方法,其中化合物II如下获得:The method of any one of claims 4-7, wherein compound II is obtained as follows:
    Figure PCTCN2021094459-appb-100007
    Figure PCTCN2021094459-appb-100007
    步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
    步骤2:选择性地脱除化合物D的异头碳保护基-SR 1,得到化合物E; Step 2: Selectively remove the anomeric carbon protecting group -SR 1 of compound D to obtain compound E;
    步骤3:在碱性条件下,将化合物E与CX 3C(=NR 4)X或CX 3CN反应得到化合物II; Step 3: Under alkaline conditions, compound E is reacted with CX 3 C(=NR 4 )X or CX 3 CN to obtain compound II;
    其中R 1、R 2和R 3如权利要求1中所定义;R 4选自H、C 1-8烷基、C 6-14芳基;X选自氟、氯、溴、碘。 Wherein R 1 , R 2 and R 3 are as defined in claim 1; R 4 is selected from H, C 1-8 alkyl, C 6-14 aryl; X is selected from fluorine, chlorine, bromine, and iodine.
  9. 如权利要求4-5中任一项所述的方法,其中化合物III可如下获得:The method of any one of claims 4-5, wherein compound III can be obtained as follows:
    Figure PCTCN2021094459-appb-100008
    Figure PCTCN2021094459-appb-100008
    步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
    步骤2:在碱性条件下,将化合物D与R 2OH反应,得到化合物F; Step 2: Under alkaline conditions, react compound D with R 2 OH to obtain compound F;
    步骤3:选择性地脱除化合物F的4位羟基保护基R 3,得到化合物III; Step 3: Selectively remove the protective group R 3 of the 4-hydroxyl group of compound F to obtain compound III;
    其中R 1、R 2和R 3如权利要求1中所定义。 Wherein R 1 , R 2 and R 3 are as defined in claim 1.
  10. 如权利要求6-9中任一项所述的方法,还包括:The method according to any one of claims 6-9, further comprising:
    Figure PCTCN2021094459-appb-100009
    Figure PCTCN2021094459-appb-100009
    步骤1:1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖与异头碳保护剂R 1SH反应,然后再进行水解反应,得化合物A; Step 1: 1,2,3,4,6-Penta-O-acetyl-D-mannanose reacts with the anomeric carbon protecting agent R 1 SH, and then undergoes a hydrolysis reaction to obtain compound A;
    步骤2:选择性地保护化合物A的2位和3位的羟基,得到化合物B;Step 2: Selectively protect the 2 and 3 hydroxyl groups of compound A to obtain compound B;
    步骤3:将化合物B的6位的羟基氧化为羧基,然后使该羧基酯化得到化合物I;Step 3: Oxidize the hydroxyl group at the 6-position of compound B to a carboxyl group, and then esterify the carboxyl group to obtain compound I;
    其中R 1和R 2如权利要求1中所定义。 Wherein R 1 and R 2 are as defined in claim 1.
  11. 如权利要求1-10中任一项所述的方法,其中,The method of any one of claims 1-10, wherein:
    R 2选自C 6-14芳基甲基或烯丙基,所述C 6-14芳基甲基任选地被C 1-8烷基、C 1-8烷氧基、卤素取代; R 2 is selected from C 6-14 arylmethyl or allyl, and the C 6-14 arylmethyl is optionally substituted by C 1-8 alkyl, C 1-8 alkoxy, or halogen;
    R 3选自C 1-8烷基酰基、C 1-8烷氧基酰基、C 6-14芳基酰基、三(C 1-8烷基)甲硅烷基、9-芴基甲氧基甲酰基、三(C 6-14芳基)甲基;其中C 1-8烷基酰基和C 1-8烷氧基酰基中的C 1-8烷基中的任一碳原子可以任选地被氧代。 R 3 is selected from C 1-8 alkyl acyl, C 1-8 alkoxy acyl, C 6-14 aryl acyl, tris (C 1-8 alkyl) silyl, 9-fluorenyl methoxymethyl Acyl, tris (C 6-14 aryl) methyl; wherein any carbon atom in the C 1-8 alkyl group in the C 1-8 alkyl acyl group and the C 1-8 alkoxy acyl group can be optionally Oxo.
  12. 如权利要求11所述的方法,其中,The method of claim 11, wherein:
    R 2选自苄基、对甲氧苄基、萘甲基、烯丙基; R 2 is selected from benzyl, p-methoxybenzyl, naphthylmethyl, and allyl;
    R 3选自乙酰基、乙酰丙酰基、三甲基硅基、叔丁基二甲基硅基、苯甲酰基、9-芴基甲氧基甲酰基、三苯甲基。 R 3 is selected from acetyl, levulinyl, trimethylsilyl, tert-butyldimethylsilyl, benzoyl, 9-fluorenylmethoxyformyl, trityl.
  13. 式I化合物:Compound of formula I:
    Figure PCTCN2021094459-appb-100010
    Figure PCTCN2021094459-appb-100010
    或其盐,其中,Or its salt, in which,
    R 1选自C 1-8烷基、任选地被C 1-8烷基取代的C 6-14芳基; R 1 is selected from C 1-8 alkyl, C 6-14 aryl optionally substituted by C 1-8 alkyl;
    R 2选自C 6-14芳基甲基或烯丙基,所述C 6-14芳基甲基任选地被C 1-8烷基、C 1-8烷氧基、卤素取代。 R 2 is selected from a C 6-14 arylmethyl group or an allyl group, and the C 6-14 arylmethyl group is optionally substituted by a C 1-8 alkyl group, a C 1-8 alkoxy group, or halogen.
  14. 如权利要求13所述的式I化合物或其盐,其中,The compound of formula I or its salt according to claim 13, wherein:
    R 1选自苯基、邻甲苯基、对甲基苯基、4-叔丁基-2-甲基苯基、2,4-二叔丁基苯基、甲基或乙基; R 1 is selected from phenyl, o-tolyl, p-methylphenyl, 4-tert-butyl-2-methylphenyl, 2,4-di-tert-butylphenyl, methyl or ethyl;
    R 2选自苄基、对甲氧苄基、萘甲基、烯丙基。 R 2 is selected from benzyl, p-methoxybenzyl, naphthylmethyl, and allyl.
  15. 如权利要求13或14所述式I化合物或其盐的制备方法,包括:The preparation method of the compound of formula I or its salt according to claim 13 or 14, comprising:
    Figure PCTCN2021094459-appb-100011
    Figure PCTCN2021094459-appb-100011
    步骤1:1,2,3,4,6-五-O-乙酰基-D-吡喃甘露糖与异头碳保护剂R 1SH反应,然后再进行碱性水解反应,得化合物A; Step 1: 1,2,3,4,6-Penta-O-acetyl-D-mannanose reacts with the anomeric carbon protecting agent R 1 SH, and then performs an alkaline hydrolysis reaction to obtain compound A;
    步骤2:选择性地保护化合物A的2位和3位的羟基,得到化合物B;Step 2: Selectively protect the 2 and 3 hydroxyl groups of compound A to obtain compound B;
    步骤3:将化合物B的6位的羟基氧化为羧基,然后使该羧基酯化得到化合物I;Step 3: Oxidize the hydroxyl group at the 6-position of compound B to a carboxyl group, and then esterify the carboxyl group to obtain compound I;
    其中R 1和R 2如权利要求13或14中所定义。 Wherein R 1 and R 2 are as defined in claim 13 or 14.
  16. 式II化合物:Compound of formula II:
    Figure PCTCN2021094459-appb-100012
    Figure PCTCN2021094459-appb-100012
    或其盐,其中,Or its salt, in which,
    R 2选自C 6-14芳基甲基或烯丙基,所述C 6-14芳基甲基任选地被C 1-8烷基、C 1-8烷氧基、卤素取代; R 2 is selected from C 6-14 arylmethyl or allyl, and the C 6-14 arylmethyl is optionally substituted by C 1-8 alkyl, C 1-8 alkoxy, or halogen;
    R 3选自C 1-8烷基酰基、C 1-8烷氧基酰基、C 6-14芳基酰基、三(C 1-8烷基)甲硅烷基、9-芴基甲氧基甲酰基、三(C 6-14芳基)甲基;其中C 1-8烷基酰基和C 1-8烷氧基酰基中的C 1-8烷基中的任一碳原子可以任选地被氧代; R 3 is selected from C 1-8 alkyl acyl, C 1-8 alkoxy acyl, C 6-14 aryl acyl, tris (C 1-8 alkyl) silyl, 9-fluorenyl methoxymethyl Acyl, tris (C 6-14 aryl) methyl; wherein any carbon atom in the C 1-8 alkyl group in the C 1-8 alkyl acyl group and the C 1-8 alkoxy acyl group can be optionally Oxo
    R 4选自氢、C 1-8烷基、C 6-14芳基; R 4 is selected from hydrogen, C 1-8 alkyl, C 6-14 aryl;
    X选自氟、氯、溴、碘。X is selected from fluorine, chlorine, bromine, and iodine.
  17. 如权利要求16所述的式II化合物或其盐,其中,The compound of formula II or its salt according to claim 16, wherein:
    R 2选自苄基、对甲氧苄基、萘甲基、烯丙基; R 2 is selected from benzyl, p-methoxybenzyl, naphthylmethyl, and allyl;
    R 3选自乙酰基、乙酰丙酰基、三甲基硅基、叔丁基二甲基硅基、苯甲酰基、9-芴基甲氧基甲酰基、三苯甲基; R 3 is selected from acetyl, levulinyl, trimethylsilyl, tert-butyldimethylsilyl, benzoyl, 9-fluorenylmethoxyformyl, trityl;
    R 4选自氢、C 1-4烷基、C 6-8芳基 R 4 is selected from hydrogen, C 1-4 alkyl, C 6-8 aryl
    X选自氯或溴。X is selected from chlorine or bromine.
  18. 如权利要求16或17所述的式II化合物或其盐的制备方法,包括:The preparation method of the compound of formula II or its salt according to claim 16 or 17, comprising:
    Figure PCTCN2021094459-appb-100013
    Figure PCTCN2021094459-appb-100013
    步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
    步骤2:选择性地脱除化合物D的异头碳保护基-SR 1,得到化合物E; Step 2: Selectively remove the anomeric carbon protecting group -SR 1 of compound D to obtain compound E;
    步骤3:在碱性条件下,将化合物E与三CX 3C(=NR 4)X或CX 3CN腈反应得到化合物II; Step 3: Under basic conditions, compound E is reacted with tri-CX 3 C(=NR 4 )X or CX 3 CN nitrile to obtain compound II;
    其中R 1如权利要求1中所定义;R 2、R 3、R 4和X如权利要求16或17中所定义。 Wherein R 1 is as defined in claim 1; R 2 , R 3 , R 4 and X are as defined in claim 16 or 17.
  19. 式III化合物:Compound of formula III:
    Figure PCTCN2021094459-appb-100014
    Figure PCTCN2021094459-appb-100014
    或其盐,其中,Or its salt, in which,
    R 2选自C 6-14芳基甲基或烯丙基,所述C 6-14芳基甲基任选地被C 1-8烷基、C 1-8烷氧基、卤素取代。 R 2 is selected from a C 6-14 arylmethyl group or an allyl group, and the C 6-14 arylmethyl group is optionally substituted by a C 1-8 alkyl group, a C 1-8 alkoxy group, or halogen.
  20. 如权利要求19所述的式III化合物或其盐,其中,The compound of formula III or its salt according to claim 19, wherein:
    R 2选自苄基,对甲氧苄基、萘甲基、烯丙基。 R 2 is selected from benzyl, p-methoxybenzyl, naphthylmethyl, and allyl.
  21. 如权利要求19或20所述的式III化合物或其盐的制备方法,包括:The preparation method of the compound of formula III or its salt according to claim 19 or 20, comprising:
    Figure PCTCN2021094459-appb-100015
    Figure PCTCN2021094459-appb-100015
    步骤1:将化合物I的4位羟基保护得到化合物D;Step 1: Protect the 4-hydroxyl of compound I to obtain compound D;
    步骤2:在碱性条件下,将化合物D与R 2OH反应,得到化合物F; Step 2: Under alkaline conditions, react compound D with R 2 OH to obtain compound F;
    步骤3:选择性地脱除化合物F的4位羟基保护基R 3,得到化合物III; Step 3: Selectively remove the protective group R 3 of the 4-hydroxyl group of compound F to obtain compound III;
    其中R 1和R 3如权利要求1中所定义,R 2如权利要求19或20中所定义。 Wherein R 1 and R 3 are as defined in claim 1, and R 2 is as defined in claim 19 or 20.
PCT/CN2021/094459 2020-05-19 2021-05-18 METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF WO2021233314A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010426751.5 2020-05-19
CN202010426751.5A CN113683650A (en) 2020-05-19 2020-05-19 Preparation method of beta-D- (1,4) -mannuronic acid oligosaccharide and intermediate thereof

Publications (1)

Publication Number Publication Date
WO2021233314A1 true WO2021233314A1 (en) 2021-11-25

Family

ID=78576086

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/094459 WO2021233314A1 (en) 2020-05-19 2021-05-18 METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF

Country Status (2)

Country Link
CN (1) CN113683650A (en)
WO (1) WO2021233314A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012138698A1 (en) * 2011-04-08 2012-10-11 Ancora Pharmaceuticals Inc. Synthesis of beta-mannuronic acid oligosaccharides
CN105541933A (en) * 2016-01-27 2016-05-04 陕西师范大学 Method for improving beta-glucosidic bond stereoselectivity through bis(trifluoromethane sulfonimide) reagent activation glycosylation reaction
WO2020070258A1 (en) * 2018-10-03 2020-04-09 Carmeda Ab Immobilised biological entities

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012138698A1 (en) * 2011-04-08 2012-10-11 Ancora Pharmaceuticals Inc. Synthesis of beta-mannuronic acid oligosaccharides
CN105541933A (en) * 2016-01-27 2016-05-04 陕西师范大学 Method for improving beta-glucosidic bond stereoselectivity through bis(trifluoromethane sulfonimide) reagent activation glycosylation reaction
WO2020070258A1 (en) * 2018-10-03 2020-04-09 Carmeda Ab Immobilised biological entities

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CODÉE JEROEN D. C., VAN DEN BOS LEENDERT J., DE JONG ANA-RAE, DINKELAAR JASPER, LODDER GERRIT, OVERKLEEFT HERMAN S., VAN DER MAREL: "The Stereodirecting Effect of the Glycosyl C5-Carboxylate Ester: Stereoselective Synthesis of β-Mannuronic Acid Alginates", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 74, no. 1, 2 January 2009 (2009-01-02), pages 38 - 47, XP055869693, ISSN: 0022-3263, DOI: 10.1021/jo8020192 *
DIMITRIOU ELENI, MILLER GAVIN J.: "Exploring a glycosylation methodology for the synthesis of hydroxamate-modified alginate building blocks", ORGANIC & BIOMOLECULAR CHEMISTRY, ROYAL SOCIETY OF CHEMISTRY, vol. 17, no. 42, 30 October 2019 (2019-10-30), pages 9321 - 9335, XP055869694, ISSN: 1477-0520, DOI: 10.1039/C9OB02053E *
MAGAUD, D. GRANDJEAN, C. DOUTHEAU, A. ANKER, D. SHEVCHIK, V. COTTE-PATTAT, N. ROBERT-BAUDOUY, J.: "Synthesis of the two monomethyl esters of the disaccharide 4-O-@a-d-galacturonosyl-d-galacturonic acid and of precursors for the preparation of higher oligomers methyl uronated in definite sequences", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 314, no. 3-4, 31 December 1998 (1998-12-31), GB , pages 189 - 199, XP004166154, ISSN: 0008-6215, DOI: 10.1016/S0008-6215(98)00312-7 *
SCHUMANN B., PRAGANI R., ANISH C., PEREIRA C. L., SEEBERGER P. H.: "Synthesis of conjugation-ready zwitterionic oligosaccharides by chemoselective thioglycoside activation", CHEMICAL SCIENCE, ROYAL SOCIETY OF CHEMISTRY, UNITED KINGDOM, vol. 5, no. 5, 1 January 2014 (2014-01-01), United Kingdom , pages 1992 - 2002, XP055869695, ISSN: 2041-6520, DOI: 10.1039/C3SC53362J *
WALVOORT MARTHE T. C., VAN DEN ELST HANS, PLANTE OBADIAH J., KRÖCK LENZ, SEEBERGER PETER H., OVERKLEEFT HERMAN S., VAN DER MAREL G: "Automated Solid-Phase Synthesis of β-Mannuronic Acid Alginates", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, ¬VERLAG CHEMIE| :, vol. 51, no. 18, 27 April 2012 (2012-04-27), pages 4393 - 4396, XP055869698, ISSN: 1433-7851, DOI: 10.1002/anie.201108744 *

Also Published As

Publication number Publication date
CN113683650A (en) 2021-11-23

Similar Documents

Publication Publication Date Title
CA2751741C (en) Process for the preparation of (-) -delta 9-tetrahydrocannabinol
KR20060091298A (en) Process for the preparation of stilbene derivatives
WO2002096899A1 (en) Synthesis of cannabinoids
CN114524856B (en) Synthesis method of high-purity plant-derived cholesterol
CN114395009B (en) High-purity cholesterol synthesis method
TW201309662A (en) A novel synthesis process of polyphenols
WO2023142460A1 (en) Method for synthesizing aryl phenol by means of reaction between aryl halide and phenol compound under induction of visible light
WO1999050258A1 (en) Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof
WO2021233314A1 (en) METHODS FOR PREPARING β-D-(1,4)-MANNURONATE OLIGOSACCHARIDE AND INTERMEDIATE THEREOF
EP1260517B1 (en) Process for preparing flavonoids
HORIE et al. Studies of the selective O-alkylation and dealkylation of flavonoids. XII.: A new, convenient method for synthesizing 3, 5-dihydroxy-6, 7-dimethoxyflavones from 3, 5, 6, 7-tetramethoxyflavones
CN114957371B (en) Process for the preparation of dydrogesterone and intermediate compounds thereof
CN113999164B (en) Preparation method of halofuginone intermediate trans-N-benzyloxycarbonyl- (3-hydroxy-2-piperidinyl) -2-propanone
CN103168045A (en) Process for the preparation of disaccharides applied to heparin pentasaccharides
WO2010122096A1 (en) Process for obtaining fluorometholone and intermediates therefor
CN114716497A (en) Method for preparing deoxycholic acid
Nakata et al. Synthetic studies of rifamycins. VIII. An improved practical synthesis of the ansa-chain compounds for the rifamycin W synthesis.
CN115716813A (en) Lindane sesquiterpene intermediate, lindane type sesquiterpene polymer prepared from intermediate and preparation method
CN113234113A (en) Method for efficiently constructing 1, 2-cis-2-nitro-glucoside and galactoside
Toyota et al. Absolute Conformation and Chiroptical Properties. VI. 2, 2', 3, 3'-Tetramethoxy-9, 9'-bitriptycyl: A Stereochemical Analog of 1, 2-Disubstituted Ethane with Identical Substituents.
WO2023035906A1 (en) Intermediate compound and preparation method therefor and application thereof
EP0621866A1 (en) Process for preparing 3-acylestratrienes and acylbenzenes
CN110981933A (en) Method for efficiently synthesizing Aramchol
US5212323A (en) Process for producing 6-(3-dimethylaminopropionyl)forskolin
US20030204100A1 (en) Process for preparation of a benzofuran derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21809353

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21809353

Country of ref document: EP

Kind code of ref document: A1